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ABSTRACT 
 
In recent years, tissue engineering of the bladder has undergone many 
technological advances.  Autologous urothelial cells have been used in animal models 
and have shown increased performance for ureteral reconstruction compared to unseeded 
grafts.  However, since patients may lack a reliable source of native urothelial cells due to 
the nature of their specific bladder disease, autologous cells are not an ideal source 
clinically, and an alternate cell source must be explored.  Adipose derived stem cells 
(ADSCs) are an attractive cell source for such regenerative medicine applications as they 
have been extensively studied for their multipotential differentiation, immunosuppressive 
properties, ease of harvest, and relative abundance.  The present doctoral thesis 
investigates the effect of growth factors present in defined keratinocyte serum-free 
medium (KSFM), all-trans retinoic acid (ATRA), and environmental conditions on 
ADSCs to explore their efficacy as a potential donor source for urothelial tissue 
regeneration.   
 Using serum-free conditions, hADSCs were exposed to defined KSFM and 
ATRA over a 21-day culture period, and effects on morphology and phenotype marker 
expression were examined. The results indicated that hADSCs differentiated towards 
urothelial-like cell lineage without co-culturing or serum-containing medium after 14 
days of culture in defined KSFM, while the effect of ATRA supplementation was limited 
to morphology changes and not on expression of markers tested.  Furthermore, a 
fibronectin/gelatin layer-by-layer coating technique was used to develop a multilayer 
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tissue construct with both undifferentiated and differentiated hADSCs (cultured using 
defined KSFM) and UROtsa cells to investigate cell morphology, protein expression, and 
dextran permeability across the multilayer construct. In hADSCs, cell aggregation 
occurred in differentiated and coated samples over 24 hours of culture in Transwell® 
inserts.  Fibronectin/gelatin coating technique applied to both UROtsa cells and growth 
membrane resulted in a multilayer with expression of CK-17, CK-20, UPIb, and ZO-1 
urothelial protein markers and less aggregation compared to hADSC. Dextran 
permeability results after 24 hours indicated diffusion of 4 and 70 kDa dextran across cell 
constructs with no differences between cell types. Lastly, a tension bioreactor system 
capable of applying constant tension on cell-seeded tissue engineering constructs was 
calibrated.  Mechanical conditioning may play a role in development of functional tissue 
in vitro to increase overall strength and compliance of tissue engineered constructs. In the 
present study, the bioreactor was tested with three materials (parafilm, PCUU, and T1107 
hybrid hydrogel) to demonstrate its capability to apply desired loading parameters based 
on user settings and to record force/distance vs. time profiles.   
 In summary, the results provide novel evidence that, through a combination of 
physical and chemical factors, hADSCs differentiate towards urothelial-like lineage 
under defined KSFM culture after 14 days. Fibronectin/gelatin cell and Transwell® 
membrane coating promotes in vitro formation of urothelial-like multilayer constructs 
using UROtsa cells. A tension bioreactor system has been calibrated to apply controlled 
mechanical force stimuli on soft biomaterials intended to reproduce the in vivo bladder 
filling for functional tissue engineering.  The knowledge gained from the present study 
 iv 
will serve as foundation for future studies focusing on multilineage and functional 
bladder tissue engineering using adipose-derived stem cells for the treatment of bladder 
disorders. 
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CHAPTER ONE 
 
INTRODUCTION AND BACKGROUND 
 
  
 
1.1. Clinical Relevance 
Approximately 400 million people worldwide suffer from bladder diseases 
ranging from congenital abnormalities to bladder cancer, which can negatively affect the 
uroepithelium of the urinary system [1].  Additionally, bladder perforation during 
transurethral resection, ureteroscopic surgery, or extraction of urethral stents can cause 
damage to the uroepithelial lining.  Current widely used clinical approaches in 
uroepithelial regeneration include grafting of gastrointestinal or buccal tissue for bladder 
augmentation or urethroplasty [1].  Inherently, functional gastrointestinal mucosa does 
not provide the proper barrier function typical of uroepithelium.  Due to this mismatch in 
properties, post-surgical complications such as electrolyte imbalance, urolithiasis, tract 
infection, mucous secretion, and malignancy develop due to tissue incompatibility in the 
urinary system [2-4].  As such, there have been many attempts in tissue engineering, both 
using synthetically- and naturally-derived methods, to find alternatives to bladder repair 
while maintaining similar compliance to native bladder tissue.  However, it is also critical 
to also understand and develop methodology for regeneration of a functional 
uroepithelium, which is key to the future success of urinary tissue engineering.  The 
following sections below will discuss bladder anatomy and physiology, the importance of 
the uroepithelium, and current methods in tissue engineering to address dysfunctional 
bladder tissue. 
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1.2. Urinary Anatomy and Physiology 
 The urinary system is critical to the regulation of the body's metabolic processes, 
electrolyte levels, and removal of wastes through urination.  A properly functioning 
urinary system relies on a coordinated signaling process that contracts and relaxes the 
bladder voluntarily during voiding and filling respectively.  During filling processes, 
urine travels from the renal pelvis of the kidneys through the ureters after an extensive 
filtration process and empties into the urinary bladder.  The established view in literature 
is that bladder stretch during filling causes stimulation of mechano-sensitive Aδ-fibers, 
which in turn signals the parasympathetic nervous system and indicates bladder fullness 
to the brain [5].  New perspectives on bladder sensation have indicated that the 
uroepithelium, also commonly referred to as urothelium, may have a role in bladder 
sensory function rather than being solely a passive tight epithelial barrier [6-12].  
Presence of primary afferent neurons and efferent nerve fibers localized near the 
urothelium provide evidence of a urothelial-associated signaling network that regulates 
bladder function and sensory signaling [13].  Details on the physiology of each organ are 
outlined below. 
1.2.1. Urinary Bladder 
The bladder is a hollow muscular organ that lies within the pelvic cavity, and 
directly contacts the uterus and vagina in females and the rectum in males. The urinary 
bladder serves as a distensible reservoir for urine collection from a pair of kidneys 
connected by ureters.  
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The two main functions of the urinary bladder are to store urine that is generated 
in the kidney and to void when necessary. During the storage phase, electrolytes are 
exchanged in the urine due to passive and active ion transport occurring at the inner 
uroepithelial layer [14].  As the bladder fills, the organ expands and begins to push 
against other organs in the pelvic cavity.  The uroepithelium structure is restructured as 
the bladder fills and changes from a transitional epithelial multilayer to a monolayer 
while apical umbrella cells change to a squamous morphology [13].  Although there is no 
exact consensus, the maximum bladder capacity is approximately 600 milliliters, while 
bladder fullness sensation can occur around 150 milliliters with discomfort at 300 
milliliters.  At this point, signals from sacral preganglionic neurons cause a rise in 
intravesical pressure, the external urethral sphincter to release, and contractions in the 
bladder wall in synchrony to allow for voiding [13].   
 1.2.2. Ureters 
The ureters are on average 25 cm long in adults and extend from the renal pelvis 
of the kidneys and empty into the urinary bladder. The ureters join the urinary bladder 
through the posterior wall by curving towards the center and entering at a slight angle.  
Underneath the inner lining of uroepithelium and lamina propria layers, smooth muscle 
fibers fill the intermediate muscularis layer and contribute to the peristaltic function. The 
outer adventitia layer contains blood and lymphatic vessels, nerves, and the connective 
tissue that keeps the ureters from dislocating. 
The urine is transported through the ureters through a combination of several 
effects including peristaltic contractions of the muscle layer, hydrostatic pressure, and 
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natural flow by gravity. As the urinary bladder fills, the expansion of the bladder wall 
closes the oblique openings of the ureters and prevents backflow of urine. The speed of 
the peristaltic waves beginning at the renal pelvis corresponds to the rate of urine 
formation within the kidneys. An increase in wave frequency corresponds to an increase 
in renal function and urine production.  
1.2.3 Urethra 
The primary function of the urethra, the terminal drainage outlet for the urinary 
system, is to allow urine to be passed out of the urinary bladder. The urethra differs 
considerably between genders. In females, the urethra extends only about 4 cm and exits 
between the clitoris and vaginal opening. The urethra contains a mucosal layer consisting 
of the lamina propria and an epithelial layer that differs along the urethral lining. The 
uroepithelium continues from the urinary bladder and covers the proximal portion of the 
urethra. Further along the urethra towards the outlet, the epithelium varies from stratified 
columnar or pseudostratified columnar to stratified squamous epithelium. The muscularis 
continues from the bladder and consists of circularly arranged smooth muscle fibers [19]. 
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Figure 1.1: A cross section of the urinary bladder. Urine is deposited into the bladder 
from the ureters in small openings in the rear. As the bladder fills, the ureters are sealed 
due to the expansion of the bladder wall preventing any backflow. The external urethral 
sphincter is a voluntary muscle that allows control of urine voiding.  
 6 
 
Figure 1.2: An overview of the urinary system. Urine is produced in the kidneys and 
passed through the renal pelvis into the ureters. The urine is stored in the urinary bladder 
for a period of time before passing through the urethra. The length of the urethra varies 
based on gender. 
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In males, not only urine, but also semen is also discharged through the urethra. 
The male urethra is approximately 20 cm long and follows a different path from the 
female urethra. The male urethra is divided into three regions. The prostatic urethra is the 
portion of the urethra that passes through the prostate. A milky secretion from the 
prostate (consisting of citric acid, proteolytic enzymes, acid phosphatase, and 
seminalplasmin as an antibiotic) is carried into the urethra through ducts in this region. 
Additionally, the vas deferens and seminal glands open into the prostatic urethra. The 
next and shortest portion, known as the intermediate urethra passes through the deep 
muscle of the perineum. Around this portion, skeletal muscle fibers are aligned in a 
circular fashion and form the external urethral sphincter muscle. The longest portion of 
the male urethra passes through the penis and is known as the spongy urethra. Similar to 
the changes in the female urethral mucosa, the uroepithelial layer continues from the 
urinary bladder and changes to stratified columnar epithelium in the intermediate urethra 
and most of the spongy urethra. 
1.2.4. Urinary Tissue Physiology 
The bladder wall tissue consists of three main layers. Starting from the interior, 
the layers consist of the uroepithelium, the lamina propria, and the detrusor.  The latter 
two will be briefly discussed, followed by an in-depth review of the uroepithelium. 
Lamina Propria 
The lamina propria is separated from the uroepithelium by the basal lamina, and 
acts as barrier between the epithelium and smooth muscle layer of the bladder. It is 
mainly composed of connective tissue made up of collagen, laminin, and elastin. Within 
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the lamina propria, one can find sensory and motor neurons along with lymphatic and 
blood vessels. The presence of unmyelinated nerves in the tissue indicate that damage to 
the lamina propria could potentially lead to disruption in normal electrical response due 
to mechanical strain in the bladder [15] The classical view is that the nerves present in the 
lamina propria respond to stretch in the bladder [16, 17], while recent studies have 
demonstrated that the signaling molecules produced in the uroepithelial layer could also 
interact with these nerves. When the bladder fills, tension is transferred between the 
lamina propria and the detrusor layers at different ranges of capacity during bladder 
filling [18]. Though the structural mechanisms on how this occurs are not well-defined, it 
appears that this transfer is what gives the bladder its unique compliant properties. 
 Detrusor  
Smooth muscle bundles form an interlaced weave spreading in all directions of 
the detrusor layer. Collagen (Type I and III), laminin, osteopontin, and hyaluronic acid is 
present and integrated with the smooth muscle fibers [19]. Fibronectin and collagen types 
I, III, and IV are produced by the bladder smooth muscle cells [20]. The detrusor muscle 
also extends towards the urethra forming an internal urethral sphincter allowing for 
retention of urine until voiding. Lack of collagen type I in this region has been shown to 
increased stress urinary incontinence in females [21]. 
Uroepithelium 
The uroepithelium, or urothelium, is a highly specialized transitional epithelial 
tissue with three distinct layers of cells identified as the basal, intermediate, and umbrella 
cells.  The umbrella cell layer allows for active sodium ion transport and a barrier 
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minimizing passive transport of molecules at the interface between the urine and 
underlying smooth muscle tissue layers, while the basal and intermediate layer provides 
progenitor cells for the umbrella layer.  The urothelium covers the inner lumen of the 
bladder, the ureters, upper urethra, and the renal pelvis.  The presence of tight junctions 
and specialized apical membrane lipids contribute to the umbrella cells’ ability to prohibit 
free movement of ions and solutes from the urine to the underlying tissue layers [14]. The 
apical membrane of the umbrella cells consists of plaque regions in between hinges. The 
plaque regions appear to be asymmetric, due to the outer leaflet being thicker than the 
inner leaflet. This asymmetry arises because of a highly crystalline structure formed by 
asymmetric unit membrane (AUM) particles composed mainly of uroplakins (UP) 
including UPIa, UPIb, UPII, UPIIIa, and UPIIIb. A glycosaminoglycan (GAGs) based 
barrier composed primarily of chondroitin and heparan sulfate also contribute to the 
protection of the tissue from the toxicity of the urine [19]. 
What causes the sensation of fullness in the bladder? The mechanisms controlling 
and signaling the afferent nerves in the bladder are still not fully resolved. Recent studies 
have shown evidence that the uroepithelium releases diffusible molecules such as 
adenosine triphosphate (ATP), acetylcholine (ACh), nitric oxide (NO), and 
prostaglandins which may interact with receptors in the afferent axons. For example, 
ATP molecules released from urothelium in response to bladder fullness act on P2X3 
receptors located in the suburothelial afferent nerve plexus [22]. It is suspected that 
epithelial sodium channels (ENaC) are responsible for detection of the mechanical 
stimuli in the uroepithelium as blocking these channels with amiloride suppresses ATP 
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release [10, 23]. The afferent signals are carried through myelinated Ad-fibers found in 
the lamina propria to the neuronal somata located in the dorsal root ganglia at S2–S4 and 
T11–L2 spinal segmental levels.  
Urination, or micturition, involves afferent signaling pathways that derive from 
the same region of the spinal cord as bladder sensation. The excitation of the efferent 
pathways for bladder wall contractions begin from the intermediolateral column of the 
S2–S4 spinal cord via ATP/ACh release. Nerves that terminate at the base of the bladder 
and urethra contain enzymes called nitric oxide synthase. Nitric oxide synthase enzymes 
create NO in order to relax the urethral muscle. Motoneurons from Onuf’s nucleus of the 
anterior horn in the S2–S4 spinal cord terminate at the striated sphincter muscle and 
release ACh to act on nicotinic receptors and relax the muscle [22]. This gives voluntary 
control to hold back urine in cases when urination is unwanted. 
1.3  Hydrogel Applications in Urologic Tissue 
1.3.1. Kidney 
The high demand for donor kidneys severely limits transplantation as an option 
for patients suffering from acute kidney injury (AKI), previously known as acute renal 
failure [24]. For this reason, stem cell therapy has been explored in recent years to 
provide an alternative solution to AKI [25, 26] although the debate remains on which 
cells are actually capable of restoring kidney function. In a study using rat models of 
AKI, hydrogels were shown to assist in stem cell seeding and viability. More specifically, 
a thermosensitive chitosan chloride hydrogel was used to deliver adipose-derived stem 
cells (ADSCs) to an ischemia-induced kidney [27]. When compared to cells injected with 
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PBS, significantly less apoptosis and increased cell proliferation of the ones seeded with 
the hydrogel was observed. Moreover, renal function, measured using the serum levels of 
creatinine and blood urea nitrogen, improved over a 28-day period with concentrations 
returning near the normal baseline in the kidneys that received the stem cell seeded with 
hydrogels. Cell retention within the hydrogel matrix is likely the key mechanism that 
contributes to the success of the implanted material. Without a substrate for cell adhesion, 
the cells are susceptible to impaired adhesion due to reactive oxygen species (ROS), 
which can lead to up to 90% cell death within the first week. In addition to providing a 
substrate for growth, the chitosan chloride hydrogel has anti-oxidative properties, which 
may curb the interaction of ROS. With the increased retention of cells, the start of 
angiogenesis and renal cell proliferation may occur earlier with the use of hydrogel 
scaffolds. With the apparent difficulty of applying free-floating cells to a targeted site in 
vivo, hydrogels will perhaps find success as a cell scaffold for renal tissue engineering, 
though there may be many hurdles in finding a cell candidate that will accurately behave 
as functional renal cells. 
An approach to consider for renal tissue regeneration is the response of the host 
tissue to the natural or synthetic hydrogel materials that might be used for cell scaffolds. 
In an attempt to restore renal function degenerated by chronic kidney disease, several 
formulations of hydrogels were used to deliver cells in a rodent model and the host 
response to the hydrogel material was evaluated [28]. Gelatin beads, cross-linked 
hyaluronic acid (HA), combination HA/gelatin, polycaprolactone (PCL), and poly(lactic-
co-glycolic acid) (PLGA) were combined with selected regenerative renal cells to 
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enhance regeneration and promote formation of functional renal tissue. While 
implantation of acellular gelatin and HA in the renal parenchyma resulted in a minimal 
immune response after 4 weeks, both PCL and PLGA initiated a severe immune response 
and promoted little native cell spreading. Only the gelatin-containing hydrogels were able 
to support cell attachment and spreading in vitro. Hyaluronic acid hydrogels did not 
provide any binding sites, and cells remained in a spheroid shape. Although the authors 
claim neo-kidney formation in vivo in rodents after one week post-implantation, the 
results of long-term studies are yet to be reported at this time [28]. 
Laparoscopic renal surgery is arguably the best treatment for renal cell carcinoma 
since its introduction in 1991 [29]. Since then, the development of surgical technique and 
equipment for laparoscopic partial nephrectomy (LPN) has provided similar benefits 
preserving renal function. However, this technique is not without its challenges especially 
because control of bleeding requires a great deal of skill from the surgeon. While 
conventional approaches include suturing and use of hemostatic gauze, hydrogel-based 
tissue sealants have also been explored as a replacement [30]. When compared to a fibrin 
sealant (Tisseel; Baxter) and intracorporeal suturing in a porcine model, the PEG-based 
CoSeal hydrogel (Baxter) was found to be a poor substitute for the fibrin glue noting that 
the hydrogel could not adhere well to the renal parenchyma [31]. More specifically, one 
animal in the CoSeal group suffered significant blood loss during surgery and was 
sacrificed after 8 days due to sepsis. Furthermore, all 3 kidneys with the CoSeal hydrogel 
suffered from urinary leakage in acute follow-up studies (after 3 days) and 1 of 4 in 
chronic follow-up studies (after 6 weeks). CoSeal also encountered bowel adhesion at the 
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site of application, which could lead to further complications in the gastrointestinal tract. 
Another study, however, demonstrated success using CoSeal in a porcine model though a 
care must be taken in interpretation as the organ section removed, hydrogel application 
method, and control of blood loss were different in these two studies [32]. Another 
hydrogel that was considered for its feasibility was a biodegradable PEG-lactide hydrogel 
photopolymerized by high intensity xenon light [33]. Although hemostasis was achieved, 
the necessity for additional tools in the operating room prevents it from being convenient 
especially for laparoscopic surgery. The contrasting results in these studies could be seen 
as evidence that factors beyond the hydrogel contribute to the success of the surgery. 
A review of 1347 LPN cases in the United States and Europe conducted in 2005 
revealed that most (n=1042) cases used a variety of different hemostatic agents and/or 
tissue sealants including gelatin matrix thrombin tissue sealant (FloSeal; Baxter), fibrin 
glue (Tisseel; Baxter), bovine serum albumin–based adhesive (BioGlue; CryoLife), and 
cyanoacrylate glue (Glubran; General Enterprise Marketing) [34]. Ultimately, the study 
found that the number of cases requiring transfusion due to blood loss and urine leakage 
were very low (2.6% and 1.9% respectively). However, it should be noted that many 
other factors play a role such as improved surgical technique and the use of other 
methods outside of tissue sealants such as suture bolstering that would improve these 
rates. It appears that hydrogels have not yet reached a point where they would have 
significant benefits over established tissue sealants in the operating room.  
 
 
 14 
1.3.2. Ureters 
Ureteral stents are used to preserve urinary drainage from the kidneys under 
situations where patency may be compromised. Common problems associated with stent 
usage include stent migration, infection, encrustation, and urothelial hyperplasia. The use 
of hydrogels in ureteral stent applications has been shown as an antibacterial coating to 
prevent infection, to enhance lubricity, and prevent encrustation [35-37]. When compared 
to uncoated control, proprietary hydrogel-coated Boston Scientific Percuflex® ureteral 
stents dipped in solutions of ciprofloxacin, gentamycin, or cefazolin exhibited an increase 
in bacterial inhibition activity following in vitro assays with activity lasting for more than 
two weeks in some specimens [35]. Specifically, ciprofloxacin provided the best results 
up to 15 days after application while gentamycin was only able to maintain bacterial 
inhibition for 3 days. Although the actual results may vary for different drugs, this study 
demonstrated that stents coated with a hydrophilic hydrogel could be simply dipped in an 
antibiotic solution prior to implant to provide protection against infection. Similarly, 
poly(vinyl pyrollidone) (PVP) hydrogel coating of ureteral stents in a similar manner 
exhibited decreased bacterial growth of E. faecalis, but not E. coli, compared to uncoated 
samples [36]. However, as a lubricant, PVP can decrease friction between implant and 
tissue and prevent complications due to trauma and irritation during removal. PVP-coated 
stents also exhibited a significant reduction of hydroxyapatite encrustation on the surface 
compared to the silicone-coating, which was previously the choice method for prevention 
of encrustation. Despite the promising results and potential benefits, hydrogel 
applications in the ureters are currently limited to coatings for stents to prevent 
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encrustation or bacterial growth. Additional biocompatibility studies and in vivo studies 
are necessary for further conclusions to be made and hydrogel-coated stents are moved 
into clinical trials. Fortunately, developments in the field of cardiovascular stents can 
often be applied in urological applications, and many ideas can be shared and adapted 
between the two fields. 
1.3.3. Bladder 
As with the kidney, one potential area of application for hydrogels is bladder 
tissue engineering. The difficulty of successfully engineering replacement bladder tissue 
can be attributed to the complexity of mimicking the bladder’s unique mechanical 
properties. Currently, there is little published work with hydrogel compound usage for 
bladder tissue engineering, and the field remains largely unexplored. While there are 
some publications on hydrogels using bladder smooth muscle cells (SMCs), there is 
currently very little on hydrogels associated with uroepithelial tissue engineering, though 
some other approaches without hydrogels have been considered.  
Collectively, bladder diseases affect approximately 400 million people worldwide 
with approximately 35 million affected in the United States with costs of $16 billion 
annually [38]. Several congenital abnormalities such as epispadias or bladder extrophy, or 
developed diseases such as bladder cancer or interstitial cystitis call for surgical 
intervention and tissue substitution. Typically, gastrointestinal segments are used for 
tissue transplantation or augmentation [39, 40]. However, due to inherent physiological 
distinctions between intestinal tissue (absorptive) and bladder tissue (excretive, barrier 
function), long term complications can include urolithiasis, increased mucous production, 
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and bladder malignancy [41]. Moreover, a shift from a contractile to a synthetic 
phenotype in bladder SMCs has been associated with scar tissue formation, which, in 
turn, create a stiffer matrix unable to expand to accommodate the change in volume. Due 
to the myriad of complications associated with grafting of gastrointestinal segments, 
tissue engineering with hydrogel matrices has emerged as a potential option for restoring 
and regenerating the bladder.  
A particular challenge in developing tissue in vitro is determining how to retain 
the normal, contractile phenotype of native bladder SMCs. A 3D hydrogel culture system 
based on poly(ethylene glycol) (PEG) cross-linked with bioactive matrix 
metalloproteinase (MMP) peptides has been examined for its effect on preserving the 
contractile phenotype of bladder SMCs and differentiation of mesenchymal stem cells 
(MSCs) into SMCs in vitro [42]. MSCs cultured in the MMP-modified PEG hydrogel 
exhibited a spread cell morphology and extracellular matrix (ECM) production while cell 
proliferation was much slower as compared to those in conventional 2D cultures. 
Moreover, a 1.7-fold increase in αSMA and 4.4-fold increase in myosin expression were 
observed in SMCs encapsulated in the PEG hydrogel compared to 2D cultures. In 
contrast, THY-1, a positive marker for the synthetic phenotype, was significantly 
downregulated in 3D culture suggesting a contractile phenotype.  MSCs from human 
bone marrow cultured in the PEG 3D system exhibited significant upregulation of smooth 
muscle markers with slight downregulation of stem cell markers. These results suggest 
successful differentiation of stem cells towards a contractile smooth muscle phenotype, 
and that the use of an easily tunable hydrogel matrix is a valuable tool to guide 
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differentiation or retain phenotypes characteristic of the native bladder smooth muscle 
cells. 
Another method for creating controllable biomaterials comes in the emerging 
field of “bioprinting”. Cells encapsulated in various hydrogel compounds are printed onto 
a cell culture dish or hydrogel substrate through an inkjet printer. Although the 
technology offers an attractive option for tissue engineering, it has met several undesired 
limitations. For example, inkjet systems [43] cannot accommodate a viscous hydrogel 
scaffold where clogging of the print head becomes an issue. Cell viability and 
functionality may also be a concern considering the high velocity and spray of the print 
head [44]. As an alternative, a valve-based droplet generator was used to print bladder 
SMC encapsulated within type-I collagen gel, and cell viability and proliferation were 
observed over a five day period [45]. Moreover, after a 51-day culture, a thin (100-400 
µm) SMC tissue patch was created with high uniformity throughout although the cells are 
smaller in diameter compared to native bladder and show little alignment along any 
particular axis possibly due to the absence of cyclic loading that is typically exerted on 
native bladder tissue [46]. Furthermore, collagen as the sole component of the bioprinted 
hydrogel makes for a mechanically weak hydrogel.  
Much work has been done on the use of natural and synthetic polymeric 
biomaterials to provide a mechanically sound scaffold with properties similar to bladder 
tissue. Some of this work goes beyond the use of hydrogels with common synthetic 
polymers used in tissue engineering such as poly(glycolic acid) (PGA), poly(lactic acid), 
and poly(ε-caprolactone) [47]. Synthetic polymers are beneficial in some cases since they 
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can be fabricated on a larger scale and have controllable mechanical properties. However, 
they lack inherent biological activity and generally suffer from biological incompatibility 
[48]. Hydrogels would likely benefit by pairing with a more mechanically stronger 
material.  One application in particular explores the use of two sheets of compressed 
collagen gel with poly(lactic acid-co-ε-caprolactone) (PLAC) embedded in between [49]. 
The collagen-PLAC material was easier to handle and was able to be sutured without 
significant shrinkage unlike its collagen-only counterpart. As such, the combination of 1) 
materials to promote cell growth and spreading, such as the bioprinting method, with 2) 
polymers capable of mimicking the bladder compliance may prove to be a viable route. 
One downside of this method, however, is the potential for release of toxic components 
from the synthetic polymer as it degrades [50, 51]. In the collagen-PLAC material, it was 
noted that a delayed immune response occurred that corresponded with the degradation 
time of PLAC [49].  
One challenge to overcome for bladder tissue engineering is developing a material 
that properly mimics, or at least incorporates well with, the native bladder tissue. 
Unfortunately at this point, hydrogels alone are too mechanically weak, and many studies 
turn to more compliant materials like synthetic polymers or decellularized grafts [48]. 
One noteworthy endeavor of uroepithelial regeneration did not rely on direct 
hydrogel application, but used cultured cell sheets on polymer-coated thermosensitive 
dishes based on the poly(N-isopropylacrylamide) (PIPAAm) hydrogel. The polymer is 
bonded to a tissue culture dish using electron beam irradiation creating a slightly 
hydrophobic surface at 37°C. On the surface, urothelial cells were cultured for three 
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weeks. After the culture period, the culture dishes are brought below the lower critical 
solution temperature (LCST) of 32°C, the surface becomes hydrophilic, and the cells 
spontaneously detach in one contiguous sheet after approximately 30 minutes. 
Histological sectioning of the cell sheets revealed both monolayered and multilayered 
sections. Electron microscopy supported the claim that the uroepithelial cells retained 
umbrella, intermediate, and basal cell morphology [52]. These uroepithelial cell sheets 
were used in a subsequent canine study in conjunction with demucosalized gastric flaps. 
Briefly, eight dogs had uroepithelial cells removed by partial cystectomy, which were 
cultured for a three-week period on the PIPAAm-coated culture dish. After this period, 
the dogs underwent surgery to have a section of stomach tissue removed and 
demucosalized. Cell sheets were then seeded and attached to the submucosal surface of 
the gastric flap, which was placed in a protective latex pouch and returned to the 
abdominal cavity. After another three weeks, the dogs were sacrificed, and the gastric 
flaps were examined. Of the eight dogs, five of them had viable regenerated uroepithelial 
layers covering a majority of the gastric flap surface. There was a change in the 
morphology of the superficial layer of cells. The remaining three dogs had severe 
hematomas on the gastric flap, which could possibly be attributed to the cell’s exposure 
to xenogenic material during the culture phase [53]. 
Approaching cell culturing from this standpoint offers the advantage of producing 
a cohesive tissue. Other cell harvesting methods using enzymatic treatment cleaves cell-
to-cell junctions and association with the extracellular matrix reducing cell function. 
However, this method of culture is also very lengthy and requires near maximum 
 20 
confluence to form a unified cell sheet. Additionally, the detachment upon temperature 
decrease occurs slowly over 30 minutes, which can lead to a decrease in cell viability. 
Several methods have been explored to improve viability and handling of the cell sheet 
[54]. 
In most cases of bladder cell carcinoma, early stages of the tumor formation 
appear in the uroepithelial layer, and treatment normally consists of transurethral 
resection of the tumor with high rates of success. Unfortunately, there are also high rates 
of tumor recurrence, and anti-cancer drugs delivery are commonly administered 
postoperatively to suppress this. However limitations arise when the drug is delivered 
orally. Additionally, large doses would have to be administered systemically in hopes of 
having a small portion reach the bladder, and thus increasing risks for side effects. 
Intravesical delivery of the drug by catheter provides a method for local release, yet this 
technique is not without its disadvantages. Low permeability of the uroepithelium 
prevents drug uptake, filling of the bladder during catheterization dilutes the drug 
concentration at the target site, and voiding of urine will carry the drug out of the bladder 
[55]. Hydrogels may provide a potential solution to prevent repeat catheterization and 
drug delivery. Ideally, a hydrogel compound loaded with drugs would be able to 
withstand bladder filling without being washed away too quickly.  
Recent studies have explored various types of thermosensitive hydrogel 
compounds that are liquid at room temperature but undergo gelation at body temperature 
to improve retention of locally delivered drugs. For example, a FITC dye was used to 
model drug elution from a tri-block copolymer hydrogel consisting of PEG-PLGA-PEG. 
 21 
The hydrogel was shown to hold FITC dye significantly better than free FITC injected 
into the bladder in rat models [56]. Urinary cystitis was also induced using an 
intraperitoneal injection of cyclophosphamide in some rats. This chemically induced 
cystitis is marked by increased micturition frequency, development of ulcers, 
hemorrhages, and erosion. Rats were divided into control groups containing saline, 
hydrogel, and misoprostol, a therapeutic drug for gastric and duodenal ulcers. The 
treatment group was injected with a hydrogel and misoprostol compound. The frequency 
of voiding significantly decreased in rats treated with the drug-loaded hydrogel compared 
to either the drug or the hydrogel delivered alone. Another similar study explored poly(N-
isopropylacrylamide) (PNIPAM) grafted with hyaluronic acid (HA) and gelatin [57].  
Cisplatin, a drug for the treatment of bladder cancer [58, 59], was added to the compound 
and drug diffusion and effects on the uroepithelium were observed in rat models. The 
study found slower release of the hydrogel-encapsulated drug compared to drug dissolved 
in aqueous solution and minimal disruption of the uroepithelial layer where the hydrogel 
was applied. 
Another bladder pathological condition that hydrogels might also offer benefits is 
interstitial cystitis (IC), which is a condition characterized by a disruption or increase in 
the permeability of the uroepithelial layer causing irritation of the smooth muscle tissue 
[60, 61]. The lack of knowledge in the etiology of IC prevents significant progress on the 
best method of treatment, and most current methods only attempt to treat the symptoms 
[62]. Some avenues of treatment have turned to glycosaminoglycans (GAG) such as 
hyaluronic acid, heparin, pentosan sulfate, and chondroitin sulfate to alleviate the pain of 
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patients suffering from IC [63-67]. Since the mechanisms of IC are not well understood, 
it was speculated that GAGs administered intravesically are providing relief by replacing 
the damaged bladder lining. However, research on the mechanisms of how GAGs could 
adhere to the glycocalyx and interact with the bladder is also lacking. Nonetheless, one 
recent study examined intravesical instillation of hyaluronic acid and chondroitin sulfate 
administered weekly for the first 2 months and then every 2 weeks for 6 months [67]. 
Based on subjective surveys, all patients reported improvement in urinary urgency and 
bladder pain. A reduction in the times voided and an increase in the volume of urine per 
voiding were seen post-treatment.   
The applications of hydrogels in the bladder have been improving over recent 
years, but still have much more to go. Though the mechanical strength of hydrogels may 
not be on par with native tissue yet, they do fare well as a supplement material for 
application that require longer-term diffusion or degradation like drug delivery or cell 
encapsulation. Additionally, discoveries in the etiology of interstitial cystitis may lead to 
more uses of natural hydrogels combined with supplemented medicine to not only relieve 
symptomatic pain, but to cure the condition altogether. 
1.3.4. Urethra 
Stress urinary incontinence (SUI) affects approximately 35% of females over the 
age of 18 and 45% over the age of 60 hampering their quality of life [68]. Economic costs 
associated with SUI, which is estimated to be $27 billion dollars annually, includes the 
purchase of disposable products, laundry costs, injuries resulting from rushing to the 
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bathroom, complications from treatment, requirement of caretakers, and lost time from 
work [69]. 
Currently the standards of treatment for SUI include pelvic floor exercise to 
strengthen the muscles surrounding the vagina and urethra and assist in retaining 
voluntary control. While surgery to implant suburethral slings made of polypropylene 
mesh is an option, potential complications and pain associated this procedure deter some 
patients. Hydrogel bulking agents are gaining popularly as an alternative for treatment of 
SUI and its effectiveness and safety were examined in a study on 514 elderly women who 
were each treated with one of four different bulking agents between 1999 and 2012 [70]. 
The commercially available bulking agents compared in this study were Contigen®, 
Zuidex®, Tegress®, and Bulkamid® made from cross-linked bovine collagen, hyaluronic 
acid/dextranomer copolymer, ethylene vinyl alcohol, and polyacrylamide hydrogel, 
respectively. The treatment for intrinsic sphincter deficiency is performed by periurethral 
injection of the hydrogel material into the submucosa to thicken the urethral wall. It is 
believed that bulking agents work by increasing the central filler volume, which 
lengthens the sarcomeres in the sphincter muscle and strengthens it [71]. Although the 
study found significant improvement in maximum urethral closure pressure and reduction 
in urine leakage, survey taken during the study revealed that patients still feared urine 
leakage and continued to take the same precautions prior to the treatment. Since the 
currently available bulking agents only provide a temporary fix to retain continence, and 
repeat injections are necessary over a period of time, recent work has explored the use of 
a composite hydrogel polyethylene glycol and carboxymethyl cellulose as a bulking 
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agent for the urethra sphincter. Allowing for little swelling or shrinkage, this particular 
hydrogel formulation can potentially become a more permanent option. However, 
additional work is necessary in order to reduce the inflammatory response and urethral 
degradation before use in humans can be considered [72]. Though bulking agent 
treatments are considered relatively safe, risks exist for urinary tract infection, urethral 
erosion and prolapse, and diverticula formation, which can require additional treatments 
with added costs. With the variability in responses to the bulking agents from patients 
[70], it remains to be seen whether a highly successful hydrogel compound will be 
developed that does not lead to severe complications and eliminates the need for repeat 
injections. 
In addition to the use as a bulking agent, hydrogels may also contribute to the 
regeneration of dysfunctional urethra. While current surgical methods rely on 
implantation of tubes created from buccal mucosa or foreskin tissue, hydrogels may be 
used instead for treatment of conditions such as hypospadias and urethral stricture. 
Hypospadias is a congenital defect found in approximately 1 in 300 male births [6] that is 
characterized by development of the urinary meatus (opening of the urethra where the 
urine exits) along the shaft of the penis rather than at the glans. One particular study 
explored the feasibility of high-density collagen gel tubes seeded with rabbit bladder 
smooth muscle cells for urethral regeneration in rabbit models [74]. At one and three 
months after implantation, urethrograms revealed that lumen calibers of acellular grafts 
were 62.69% ± 18.1% and 42.4% ± 34.3% compared to native control urethra, 
respectively. In contrast, the lumen calibers of seeded grafts were 45.7% ± 43.62% at one 
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month and 96.6% ± 12.5% at three months. The observations that host cell ingrowth 
occurred in both acellular and seeded scaffolds suggest that use of the acellular scaffold 
will eliminate the time necessary to harvest and expand smooth muscle cells for seeding 
and the collagen gel approach may potentially improve short- and long-term 
complications over current surgical methods. In surgical cases where radical urethral 
repair or replacement is not necessary, glues or sealants are used to repair damaged 
tissues. Urethrocutaneous fistula is a post-operative complication of hypospadias repair, 
and its incidence can be as high as 20% [75]. The use of fibrin glue as a sealant applied 
along the suture lines during hypospadias repair has been shown to diminish occurrence 
rate of complications from 53% to 20% [76]. Fibrin glue can also be used to promote 
wound healing in many cases urethroplasty, such as those previously described, and to 
assist with bulbar urethroplasty using buccal mucosa grafts [77,78].  
Various types of hydrogels are used not only in urethral reconstruction, but also as 
a coating material for devices that come in contact with the tissue. In both ureteral stents 
and urethral catheters, problems with infection, lubricity, and encrustation can occur. 
Several stents and catheters are on the market using proprietary hydrogel coatings such as 
LubriLAST™, HydroPlus™, the BIOCATH® and LUBRI-SIL® Foley catheter. 
However, these hydrogels are all advertised to improve only patient comfort by providing 
adequate lubrication. Further improvements in hydrogels used for stents and catheters 
will likely be found through developments that prevent bacterial growth and encrustation. 
For urethral catheters made from segmented polyurethane, surface modifications are used 
to reduce the complications such as bacterial colonization, urethral trauma, catheter 
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obstruction, encrustation, and infection [36, 79-81]. The adhesion and growth of bacteria 
around the catheter site arises from the protein adsorption cascade [82]. Furthermore, 
irritation and inflammation due to the friction between the catheter and the urethral lining 
can exacerbate the complications mentioned. Particularly, one study compared the protein 
reduction and lubrication properties of a chitosan/poly(vinyl alcohol) (PVA) hydrogel 
with LubriLAST™, a general solution currently used to create a lubricated surface for 
several devices including urinary catheters. Long-chain chitosan provides a flexible 
network for entanglement of PVA that is designed to elute from the chitosan network 
upon swelling. These particular components were chosen for their antimicrobial 
capabilities (chitosan) and reduction of protein adsorption and cell adhesion (PVA). 
Results of the study showed significantly less protein adsorption on the chitosan/PVA-
coated catheters compared to uncoated and LubriLAST™ coated samples. Additionally, 
antibacterial tests measuring areas of bacterial inhibition were performed and large 
antiseptic regions were demonstrated around the chitosan/PVA-coated samples when 
incubated with S. aureus, P. aeruginosa, and E. coli [83]. 
1.4.  Tissue Engineering of Bladder 
 1.4.1.  Importance of a functional urothelial layer 
 The urothelium accomplishes this through high-resistant tight junctions, glycan 
layer, and specialized protein and lipid composition present in the umbrella, or 
uppermost, cell layer. There is evidence that the uroepithelium also plays a role in the 
control of active transport of molecules, ions, and water across the mucosal surface of the 
bladder. Active release of neurotransmitters such as adenosine triphosphate (ATP), 
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acetylcholine, and adenosine from the urothelial layer to various nerve processes in the 
underlying tissue may play a role in the sensation of bladder fullness [14]. It is 
hypothesized that interruption of the urothelial layer and the sensory functions associated 
with it leads to bladder dysfunction and certain bladder diseases such as interstitial 
cystitis [84]. Current clinical methods explore the use of buccal mucosa or segments of 
the gastrointestinal tract as donor tissue for diseased bladder, however contact of the 
foreign tissue can contribute to complications such as urolithiasis, increase mucus 
production, malignancy, infection, and metabolic disturbances for the patient [41, 85-87]. 
Ultimately, it would be desirable to produce transplantable tissue that would be capable 
of handling the in vivo conditions of the urinary tract.  
 1.4.2. Adipose-derived stem cells for therapeutic benefits 
Throughout the lifespan of a person, the adipose tissue on their body can undergo 
drastic changes in volume.  In some cases, small increases in the lipid amount in each 
adipocyte contribute to small volume fluctuations while larger increases remodel the 
adipose tissue through production of new adipocytes.  Research has shown that 
progenitor cells and stem cells within the adipose tissue contribute to the radical 
remodeling that can occur within the adipose vasculature.  One population of cells that 
have been isolated from adipose tissue has been termed as adipose derived stem cells 
(ADSCs).  In literature, there have been several names for the cell population including 
adipose-derived adult stem cells (ADAS), processed lipoaspirate cells (PLA), and adipose 
tissue-derived stromal cells.  
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ADSCs have been extensively studied for their multipotent differentiation 
potential, and the prospects for their use in tissue regeneration have been proposed for a 
variety of different applications. Mesenchyme-derived adult stem cells (MSCs) such as 
ADSCs and bone marrow-derived stem cells (BMSCs) provide an alternative to the hotly 
debated embryonic stem cells while still having a similar differentiation potential. 
BMSCs are capable of differentiation into adipocytes, chondrocytes, osteoblasts, and 
myoblasts [88-93] with in vitro studies. Practically, however, harvesting BMSCs can 
cause pain and morbidity at the extraction site, and expected low cell yields necessitate 
an ex vivo expansion, which is costly and time consuming in itself. Instead, ADSCs may 
provide an alternative source for adult stem cells with a higher cell yield per harvest, 
lower pain and discomfort for the patient, and relative ease of harvest [94].  ADSCs are 
extracted through an established method in which human raw lipoaspirate from such 
liposuction procedures is processed to yield an adult stem cell population [95]. The same 
group showed that the ADSCs within this processed lipoaspirate possess the capacity to 
differentiate into adipose, bone, cartilage, and muscle. Furthermore, there has been 
research showing the capability of ADSCs to differentiate towards skeletal muscle [96-
98], cardiac muscle [99-101], neuronal cells [102-104], hematopoietic cells [105], 
endothelial cells [106], and hepatocytes [107].   
Another reason that ADSCs are an attractive cell source for stem cell-based tissue 
engineering is due to their immunomodulatory capabilities.  These characteristics were 
first studied in autologous mesenchymal stem cells due to their wide usage in therapeutic 
treatment for various diseases such as urinary incontinence and erectile dysfunction, 
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though a number of studies explored the potential for allogeneic and xenogeneic 
transplantation [108, 109].  The first studies that explored the immunosuppressive 
properties of the ADSCs were shown in their ability to prevent a mixed lymphocyte 
reaction – though it is not clear whether or not this requires direct cell-cell contact [110-
112].  Literature has shown that immunosuppression occurs not through cell-cell contact, 
but rather through the secretion of soluble factors such as prostaglandin E2, indoleamine 
2,3 dioxygenase and leukemia inhibitory factor [112-115].  In studies where those 
specific soluble factors were inhibited, the response demonstrated a neutralization of the 
immunomodulatory effect of the ADSCs [113-115]. Though there are many strict 
guidelines that are yet to be thoroughly established in stem cell therapy, the 
immunosuppressive capabilities demonstrated put ADSCs at the forefront of therapeutic 
options.  With allotransplant, there is potential to establish a stem cell bank in which 
ADSCs can be differentiated, stored, and delivered when necessary without having to 
harvest autologous tissue and undergo an extensive culture and expansion period. 
1.4.3. Adipose-derived stem cells for epithelial differentiation 
Since the ultimate goal of this research is to derive uroepithelial cells from 
ADSCs, we are interested in the epithelial potential of this cell population. Several 
previous studies have sought an answer to whether or not cell types originating from the 
mesenchyme – such as BSMCs or ADSCs – are capable of differentiation towards 
epithelial lineages using soluble factors in media.  Previously, BMSCs have been shown 
to be capable of in vitro differentiation towards epithelial-like lineage using varying 
differentiation modalities including growth factors, conditioned media, co-culture, a 
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biomimetic environment, or a combination of these methods [116-119].  One particular 
study speculated that retinoids would be capable of stimulating epithelial differentiation 
in ADSCs due to its anti-proliferative and effect on differentiation in various tissue types 
[120].  The results from the study demonstrate an increase in cytokeratin 18 – a highly 
conserved keratin important in cell polarization and typical of simple epithelial (such as 
in intestine or kidney) – in both protein and mRNA expression after exposure to 5 µM 
all-trans retinoic acid (ATRA) after 10 days.  Conversely, there was a decrease in the 
expression of vimentin – a mesenchymal marker [121].  Aside from ATRA, epidermal 
growth factor (EGF), keratinocyte growth factor (KGF), and hepatocyte growth factor 
(HGF) have all been implicated to induce a change in expression of ADSCs in vitro [122-
124].  One study aimed to use the listed growth factors in various concentrations to 
determine their combinatorial effects in an air-liquid interface created with a Transwell® 
membrane [179].  The study found the highest upregulation of cytokeratin 19 (CK-19) 
mRNA expression with the addition of ATRA, hydrocortisone, EGF, HGF, and KGF and 
similar trends with protein expression of CK-19, cytokeratin 13 (CK-13), and involucrin 
– another terminal epithelial marker.  Though positive results were shown of epithelial 
differentiation of these rabbit ADSCs, it is unclear if uroepithelial differentiation was 
achieved due to the lack of detection for urothelial specific markers.  Furthermore, the 
necessity of the air-liquid interface as a culturing method was not tested and would 
ultimately act as a chokepoint to culture a large number of cells effectively. 
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CHAPTER TWO 
 
RATIONALE AND SPECIFIC AIMS 
2.1. Rationale 
 Various urological treatment approaches such as transurethral resection, bladder 
cancer, and ureteroscopic surgery can cause damage to the urothelial lining tissues. 
Current gold standard in bladder tissue regeneration, however, are limited to 
gastrointestinal or buccal tissue augmentation, which can lead to severe consequences 
such as urolithiasis, electrolyte imbalance, tract infection, and mucus production [85].  
Currently, no suitable method exists, particularly in cases of bladder cancer, to restore the 
urothelial layer from a non-urothelial cell source.  Due to the nature of bladder cancer 
pathology, the use of native urothelial cells is severely restricted in cases of bladder 
cancer and disease [18] despite their successes with tissue regeneration in vitro [133, 134, 
146] and in vivo [53, 149, 150, 169].  The long-term goal of the present study is to 
develop a therapeutic system using defined keratinocyte serum-free media to consistently 
differentiate human adipose-derived stem cells (hADSCs) towards a urothelial lineage, 
which can be used to promote repair and restoration of a functional uroepithelial lining. 
Human ADSCs are a desirable cell source due to their ease of harvest and propagation, 
and evidence of immuno-modulatory properties allowing for allogeneic or even 
xenogeneic transplantation without use of immunosuppressants (Lin CS, Stem Cells and 
Development. 2012; 21: 2770-78).  Thus far, attempts in differentiating ADSCs towards 
urothelial and epithelial lineages included the use of co-culturing and conditioned media, 
which relied on multiple cell sources and have provided unreliable and inconsistent 
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results [136-139]. In order to translate the successes obtained in cell culture studies to a 
more physiologically relevant growth environment, research continues to investigate 
development of three-dimensional tissue-engineered constructs to replicate bladder 
physiology [7-9]. Hydrogels have also been explored in tissue regeneration as a method 
to deliver cells, provide essential growth factors, and control cell growth at a target site 
[132]. The use of adult stem cells continues to be a challenge in replicating urothelial 
physiology, as it is not a straightforward task to mimic complex characteristics such as 
urothelial impermeability and rapid changes in the urothelial umbrella layer associated 
with bladder compliance and distention, which is especially the case for cells not initially 
suited for such purposes. 
2.2. Specific Aims 
 In pursuit of our research goals, human ADSCs were cultured in various culture 
conditions to test the effects of defined keratinocyte serum-free media and all-trans 
retinoic acid (ATRA) on cell differentiation.  After prescribed time periods, cell 
differentiation towards a urothelial cell lineage was assessed through morphological 
imaging, reverse transcription and polymerase chain reaction (RT-PCR) for mRNA 
expression of urothelial and stem cell markers, and translation of such markers to protein 
expression via western blotting and immunofluorescence studies.  Furthermore, some 
preliminary studies were conducted on investigating the cellular response in 3D matrix 
using collagen, PMBV/PVA hydrogel, and fibronectin/gelatin layer-by-layer method.  
The dissertation is dividing into the follow aim sections as follows: 
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1. Evaluating the effects of defined keratinocyte serum-free media on mRNA gene 
and protein expression of hADSCs towards a urothelial lineage via reverse-
transcription and polymerase chain-reaction, western blotting, and 
immunofluoresence. 
2. Evaluating the effects of a fibronectin/gelatin layer-by-layer coating on 
morphology and urothelial marker expression of urothelial-like cells in a three-
dimensional microenvironment. 
3. Development of a tension bioreactor system for the application of static stretch in 
a viscoelastic environment susceptible to creep behavior. 
Upon completion of these aims, we expect to illuminate the key components in 
developing a reliable and consistent differentiation method for hADSCs towards 
urothelial lineage.  Furthermore, we hope to advance the research in development of a 
functional urothelial multilayer in vitro using non-native cell sources for stem cell 
therapies. 
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CHAPTER THREE 
 
EFFECTS OF KERATINOCYTE-SERUM FREE MEDIA ON UROTHELIAL 
PHENOTYPIC EXPRESSION IN ADIPOSE DERIVED STEM CELLS 
 
3.1. Introduction 
Various congenital and adult bladder diseases require approximately 60,000 
surgical interventions annually in the US [140-142] and many of the procedures can 
permanently damage the urothelial tissue along the urinary tract.  Current standard 
approaches substitute damaged urothelial tissue with gastrointestinal or buccal mucosa, 
or in cases of bladder cancer, abnormal urothelium is removed in a transurethral resection 
procedure leaving the underlying layers exposed to the urine [85].  In both cases, the 
urine contacting the smooth muscle layer leads to unwanted complications such as 
electrolyte imbalance, urolithiasis, tract infections and mucus production [41, 87].  It is 
critical to develop a methodology for clinical use to restore the urothelium especially 
from a non-urothelial cell source.   
Although tissue engineering of the bladder has received much attention [143-
145], use of synthetic or natural scaffolds to repair dysfunctional urologic tissue has seen 
limited success compared to conventional treatment [146]. For example, naturally derived 
materials such as submucosa of bladder or small intestine, collagen in various forms, or 
alginate gel have been used to facilitate incorporation of the implanted cells and elicit a 
biological response conducive to formation of neo tissue [144].  Synthetic polymeric 
biomaterials such as polyglycolic acid (PGA), poly-L-lactic acid (PLA), or poly(lactic-
co-glycolic acid) (PLGA) or a hybrid of naturally and synthetically derived materials 
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have also been used. The advantage of synthetic materials is their scalability, quick and 
reproducible production, and mechanically tunable properties [52, 147, 148].  However, 
more studies are focused on materials for regenerating smooth muscle tissue and not on 
the urothelial layer.   Shiroyanagi et al. reported that using canine urothelial cells seeded 
onto thermally sensitive polymer surfaces coated with poly(N-isopropylacrylamide) 
(PIPAAm) formed thin, stratified cell sheets retaining urothelial phenotypic markers after 
three weeks post-harvest [52].  In a follow-up study, the cell sheets were grafted onto 
demucosalized gastric flaps and implanted into the stomach of a canine model with 
similar morphological traits to native urothelial tissue, though regenerated urothelium 
lacked urothelial-specific uroplakin markers [53].  Additionally, autologous cells have 
been used for ureteral reconstruction [149] and urethral defect repair [150, 151] in animal 
models to prevent restenosis compared to tissue constructs without use of natively-
derived urothelial cells. Though the results are promising, seeding with autologous 
urothelial cells from a diseased donor site is ill-advised due to the nature of bladder 
cancer pathogenesis [152]. As such, alternate and reliable sources for cells must be 
considered. In this study, we explore the potential for adipose derived stem cells as an 
alternative cell source to differentiate into urothelial-like cells for bladder regeneration.   
Adipose derived stem cells (ADSCs) are adult stem cells extracted from raw 
lipoaspirate [153] and have been extensively studied for their multipotential 
differentiation into various lineages such as adipocytes, chondrocytes, osteoblasts, and 
myoblasts [153, 154]. Although bone marrow-derived stem cells (BMSCs) are capable of 
similar differentiation, harvesting BMSCs can cause pain and morbidity at the extraction 
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site, and expected low cell yields necessitate an ex vivo expansion, which is more costly 
and time consuming compared to harvesting of ADSCs [94, 153, 154].  Furthermore, 
ADSCs have been shown to exhibit immunosuppressive properties possibly and can 
decrease alloreactivity when implanted [110, 155]. For these reasons, ADSCs are an 
attractive cell source for regenerative medicine applications and we chose to use them in 
the present study.  
Others have attempted the urothelial differentiation of ADSCs using various 
approaches including media supplementation with all-trans retinoic acid (ATRA) [121], 
co-culturing with or conditioned media from additional cell lines [136-139].  Although 
discrepancies in interpretation for the specific cause of urothelial phenotype upregulation 
exist between results, these studies indicate evidence of an association between 
urothelium-associated marker expression and soluble factors in the growth media.  
Furthermore, another drawback in these studies is the xenogeneic use of bovine-derived 
products, where the undefined chemical profile of fetal bovine serum lends itself to less 
control over the differentiation process [156].  In search of alternatives to bovine-derived 
products and supplemental cell lines for cell differentiation, we hypothesized that 
consistent differentiation towards urothelial lineage could be achieved in hADSCs using 
defined keratinocyte serum-free media (supplemented with epidermal growth factor) 
because it has been used to retain phenotype in human urothelial cell culture [157-159]. 
The present study explored the effects of defined keratinocyte serum-free media and 
ATRA on differentiation of ADSCs into urothelial lineage. Specifically, the morphology 
and cell viability was observed via phase-contrast and fluorescence staining, and mRNA 
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and protein expression profile were examined using reverse transcription, polymerase 
chain reaction, western blotting, and immunofluorescence techniques. 
 
3.2. Materials and Methods 
Cell culture.  
Human adipose derived stem cells (hADSCs) were purchased from Lonza (PT-
5006) and expanded in low D-glucose (1000 mg/L) DMEM (Life Technologies) 
supplemented with 10% fetal bovine serum (FBS, Fisher), 1% GlutaMAX (Life 
Technologies), and 1% antibiotic/antimycotic solution (AB/AM; Life Technologies).  For 
differentiation towards urothelial lineage, hADSCs at approximately 2.5x105 cells/cm2 
were cultured in defined keratinocyte serum-free media with the growth supplement kit 
provided by the manufacturer (fibroblast growth factor (FGF), epidermal growth factor 
(EGF), and insulin; Life Technologies) and 1% AB/AM in the presence or absence of 5 
µM all-trans retinoic acid (ATRA, Sigma) for 7, 14, and 21 days. HADSC between 
passages 3 and 7 were used in all experiments of the present study. UROtsa cells, an 
immortalized normal human urothelial cell line (kindly donated by the laboratory of Dr. 
Naoki Yoshimura, Department of Urology, University of Pittsburgh), were cultured in 
DMEM supplemented with 5% FBS, 1% AB/AM solution, and without GlutaMAX. For 
a co-culture experiment, rat bladder smooth muscle cells (rBSMCs) were harvested as 
described previously [160] and the cells under passage 10 were used as a feeder layer. In 
separate experiments, human ADSCs were pre-labeled with Celltracker Red CMPTX 
(Molecular Probes), encapsulated in a collagen gel (2 mg/ml type I collagen, MP 
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Biomedicals; DMEM, 10% FBS), and cultured in DMEM or defined KSFM with 2% 
FBS in presence or absence of the rBSMC feeder layer for 7 days.   
Reverse transcription / polymerase chain reaction  
  At the end of the prescribed time periods, total RNA was collected from the cells 
using Qiagen RNeasy Mini Kit according to the manufacturer’s instructions (Qiagen) and 
quantified using Thermo Scientific Nanodrop 2000c UV-Vis Spectrophotometer.  
Complementary DNA (cDNA) was synthesized from 2 µg of total RNA using the 
MMLV-RT reverse transcriptase in the RETROscript® Kit (Life Technologies).  The 
resulting cDNA was amplified in the polymerase chain reaction using the HotStarTaq 
DNA polymerase in the QuantiTect SYBR Green PCR Kit and a Rotor-Gene (RG-3000, 
Corbett Research) Thermal Cycler.  Custom primers (Table 3.1) were used to assess 
expression levels of cytokeratin 17 and 20 (CK-17, CK-20) for epithelial cell 
differentiation, uroplakins Ib and II (UPIb, UPII) for urothelial cell differentiation, and 
CD90 and CD105 for mesenchymal stem cell markers.  Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was used as the endogenous control. For the PCR cycles, the 
DNA denaturation step was set at 95°C followed by primer annealing at 55°C and primer 
extension at 72°C for 40 cycles. Gene expression levels of differentiated cells were 
analyzed and compared to those of the control hADSC using the comparative delta Ct 
method. Statistical analysis of RT-PCR results was conducted using a one-sample 
student's t-test to compare the mean Ct values of control and experimental groups.  A 
statistical significance was defined as p-value ≤ 0.05.  
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Gene GenBank ID Sequence (5'–3') 
Cytokeratin 17 NM_000422.2 F: CCGCACCAAGTTTGAGACAG   
R: TTCAGGTAGGCCAGCTCCTC   
Cytokeratin 20 NM_019010.2 F: TGGATTTCAGTCGCAGAAGC   
R: CATAAACGCTGGGTGTCGTC   
Uroplakin Ib NM_006952.3 F: TTGCTGTGGCGTAAATGGTC   
R: GCCTCCAGGTTGAGAGGTTC   
Uroplakin II NM_006760.3 F: GCCCTTGATCCTGATTCTGC   
R: ACCAGCAGGCTCTCCGTTAG   
CD90 NM_006288.3 F:AGAGCCTCCGTCTGGACTGC 
R:GAGCGGTATGTGTGCTCAGG 
CD105 NM_001114753.2 F:AGCTGACTCTCCAGGCATCC 
R:GCCTGGATTTGTAGGCCAAG 
GAPDH M32599 F: ACCACAGTCCATGCCATCAC 
R: TCCACCACCCTGTTGCTGTA 
 
Table 3.1: Gene name and nucleotide sequence of the primers.  
 
 
Cell Immunofluorescence and Morphological Imaging  
Cells were fixed using a 4% paraformaldehyde solution for 20 minutes and 
washed thoroughly using PBS. Blocking solution (PBS with 2% goat serum albumin with 
added dilute Triton X-100) was added and cells were permeabilized at room temperature 
for 30 minutes before they were incubated with mouse monoclonal anti-cytokeratin 17 
(CK-17, Sigma, C9179), goat polyclonal anti-cytokeratin 20 (CK-20, Santa Cruz 
Biotechnology, SC-17113), or goat polyclonal anti-uroplakin Ib (UPIb, SCBT, SC-
15174) at 4°C overnight. All primary antibodies were used at a 1:100 dilution in PBS. 
For detection of membrane-bound UPIb, Triton X-100 was omitted from the blocking 
solution. Following primary antibody conjugation, species-specific fluorescently labeled 
(FITC or Alexa Fluor 488) secondary antibody was added at a 1:1000 dilution in PBS 
and incubated at room temperature for one hour. Cell nuclei were then stained with 300 
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nM DAPI in PBS for 5 minutes followed by dehydration using ethanol. For general 
morphological examination, phase contrast images of hADSCs under different media 
conditions and UROtsa cells grown in DMEM were compared after 10 days.  
Additionally, actin filaments in hADSCs and UROtsa cells in two-dimensional cultures 
were probed with rhodamine phalloidin and imaged to examine cell morphology after 10 
days.  For co-culture experiments, cell viability in hADSCs and rBSMCs were detected 
using Live/Dead assay (Molecular Probes) and detection of CK-17 presence via 
immunofluorescence was performed.  All images were taken on a Nikon epifluorescence 
microscope (TE-2000S) and a Hamamatsu digital camera (C4742-95).   
Western Blot   
At the end of the culture period, cells were washed using ice-cold PBS and lysed 
using Radio Immuno Precipitation Assay (RIPA) buffer consisting of 150 mM sodium 
chloride, 1.0% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris at pH 
8.0 and a protease inhibitor cocktail (Abcam).  After centrifugation of the lysates to pellet 
the insoluble materials, supernatant was collected and concentration of protein sample 
was determined using a Bradford protein assay (Pierce). Proteins and a standard ladder 
(Life, LC5800) were separated on a 4-15% gradient polyacrylamide gel (Bio-Rad). 
Proteins on the gel were then transferred via wet electroblotting (tank transfer) to Immun-
blot® PVDF membrane (Bio-Rad) in transfer buffer solution. Membranes were blocked 
using 2% nonfat dry milk (NFDM) in 50 mM Tris buffer (pH 8.0).  The proteins of 
interest were detected with the following primary antibodies at a 1:500 dilution in 1% 
NFDM with Tris buffer at 4°C overnight: mouse monoclonal anti-CK17, goat polyclonal 
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anti-CK20, goat polyclonal anti-UPIb, and mouse monoclonal anti-GAPDH (Life, 
AM4300) and species-specific HRP-conjugated secondary antibodies at 1:5000 dilution 
in 1% NFDM with Tris buffer. Protein bands on the membranes were imaged using 
chemi-luminesccence and analyzed using ChemiDoc™ XRS+ Molecular Imager with 
ImageLab software (BioRad).   
3.3. Results 
Morphological changes of hADSCs  
Images of hADSCs after rhodamine phalloidin staining provide evidence that 
cells grown in DMEM alone exhibit an elongated spindle-like morphology typical of 
mesenchyme-derived stem cells (Figure 3.1.A). After 10 days of culture in defined 
KSFM, hADSC exhibited the small cobblestone-like morphology with a reduction of 
elongated actin filament expression (Figure 3.1.C) similar to the positive control, UROtsa 
cells (Figure 3.1.B).  When hADSCs were grown in the presence of 5 µM ATRA, cells 
displayed contact growth inhibition and formed a monolayer typical of epithelial cells in 
10 days (Figure 3.1.D and 3.1.E).  Phase contrast imaging provided further evidence that 
hADSCs cultured in defined KSFM exhibited cell morphology similar to that of UROtsa 
cells (Figure 3.2). 
Expression of urothelial and stem cell marker mRNA 
The results of real time RT-PCR provided evidence that mRNA expression for 
one of the urothelial cell markers tested, CK-17, by hADSC exposed to what media was 
significantly (p < 0.01) lower when compared to that of undifferentiated hADSCs 
maintained under DMEM control media at all time points tested (Figure 3.3).  In contrast,  
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Figure 3.1: Fluorescence imaging of hADSCs with rhodamine phalloidin staining for 
F-actin filaments.  Undifferentiated hADSCs (A) exhibit an elongated morphology.  
Culturing hADSCs in defined KSFM for 10 days (B) shifted cells towards a smaller 
cobblestone-like with reduction of internal actin, while the addition of 5 µM ATRA to the 
media caused hADSCs to retain actin filaments (C).  hADSCs cultured in DMEM with 5 
µM ATRA (D) displayed spread morphology with actin filaments.  UROtsa cells were 
used as positive control for comparison (E).  Scale bars = 100 µm 
 
CK-20 mRNA expression in hADSC cultured in KSFM increased approximately ten-fold 
compared to the undifferentiated state after one week and continued to increase over two 
and three weeks of culture. Moreover, significant increases in UPIb mRNA expression 
occurred in cells cultured under both KSFM and KSFM with 5 µM ATRA, with the 
highest upregulation after 21 days in KSFM with 5 µM ATRA.  Finally, hADSC cultured  
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Figure 3.2: Phase contrast imaging of hADSCs.  Undifferentiated hADSCs (A) exhibit 
an elongated morphology with long cell extensions.  In contrast, UROtsa cells (B) display 
a smaller cobblestone-like morphology and appear to form colonies of cells.  After 10 
days in incubation with defined KSFM, hADSC morphology appears to shift towards 
urothelial-like cells (C).  Scale bars = 100 µm. 
 
in KSFM exhibited significant (p < 0.01) downregulation of CD90 and CD105 markers 
after 2 weeks indicating differentiation away from the stem cell characteristics.   
Urothelial cell marker protein expression in hADSCs   
Western blot analysis revealed that greater expression of CK-20 was present in hADSCs 
cultured in KSFM for up to 21 days compared to cells cultured in all other media (Figure 
3.4).  However, neither CK-17 nor UPIb expression was detected in any of the groups by 
the western blot analysis.  Additionally, it was concluded that transmembrane markers 
could not be visualized using the prescribed protein isolation procedure for western 
blotting due to the circumstance that protein aggregation was occurring during the 
denaturation process (not pictured).  To verify the changes in protein expression seen by 
western blotting, immunofluorescence staining of hADSC was performed for 7, 14, and 
21 days (Figure 3.5-3.7).  The results of immunostaining demonstrated that expression of  
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Figure 3.3: Relative expression ratios of mRNA markers in hADSCs under media 
conditions after 7, 14, and 21 days.  Error bars indicate ± 2 S.D.  Stars indicate 
significant difference in expression compared to control undifferentiated hADSCs 
(normalized with R.E.R. of 1) using one-sample student's t-test (*: p-value < 0.05; **: p-
value < 0.01).  All values for CK17 are significantly different with values of p < 0.01.   
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Figure 3.4: Images of western blots to detect protein expression in hADSCs under 
indicated media conditions after 7, 14, and 21 days. Expression of all three markers 
was notably absent from undifferentiated hADSCs cultured in control DMEM media.  
UPIb expression was also absent from each group.  
 
CK-20 with the characteristic appearance of cytoskeletal intermediate-filaments was 
present strongly in hADSCs incubated in defined KSFM with or without ATRA. In 
addition, UPIb expression was detected as early as 7 days in cells cultured in defined 
KSFM with and without 5 µM ATRA.  However, CK-17 expression was absent in 
hADSC cultured under all supplementation conditions tested in the present study.   
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Phenotype and Viability in Smooth Muscle Cell Co-culture.  
Human ADSCs encapsulated within a collagen hydrogel revealed distinct CK-17 
expression when supplemented with keratinocyte serum-free media both with and 
without the presence of a rat BSMC feeder layer (Figure 3.8).  This CK-17 expression 
was not seen with hADSCs seeded under identical condition supplemented with control 
DMEM.  The expression was further visualized in a comparison of CK-17, CK-20, and 
UPIb expression in hADSCs cultured in both KSFM and DMEM for 7 days.  After the 
prescribed period, fluorescence images indicate that CK-17 protein is expressed solely in 
hADSCs encapsulated in 3D collagen hydrogel under KSFM culture, while all other 
proteins are absent in both KSFM and DMEM (Figure 3.9). Additionally, fluorescence 
images show cell viability of both cell types after Live/Dead assay through the one-week 
culture period (Figure 3.10). 
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Figure 3.5: Immunofluorescence imaging of hADSCs at 7 days. Undifferentiated 
hADSCs in control DMEM (A, E, I, M), hADSCs cultured in DMEM with 5 µM ATRA 
(B, F, J, N), in defined KSFM (C, G, K, O), and defined KSFM with 5 µM ATRA (D, H, 
L, P) after 7 day differentiation regimen.  Green fluorescence is indicative of CK-17 
protein expression in the first row (A-D), CK-20 expression in the second row (E-H), and 
UPIb expression in the third row (I-L). Non-specific binding of second antibody (no 
primary Ab control) was tested for each cell group with no background staining detected 
in the fourth row (M-P). Scale bar = 100 µm. 
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Figure 3.6: Immunofluorescence imaging of hADSCs at 14 days. Undifferentiated 
hADSCs in control DMEM (A, E, I), hADSCs cultured in DMEM with 5 µM ATRA (B, 
F, J), in defined KSFM (C, G, K), and defined KSFM with 5 µM ATRA (D, H, L) after 
14 day differentiation regimen.  Green fluorescence is indicative of CK-17 protein 
expression in the first row (A-D), CK-20 expression in the second row (E-H), and UPIb 
expression in the third row (I-L).  Scale bar = 100 µm. 
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Figure 3.7: Immunofluorescence imaging of hADSCs at 21 days. Undifferentiated 
hADSCs in control DMEM (A, E, I), hADSCs cultured in DMEM with 5 µM ATRA (B, 
F, J), in defined KSFM (C, G, K), and defined KSFM with 5 µM ATRA (D, H, L) after 
21 day differentiation regimen.  Green fluorescence is indicative of CK-17 protein 
expression in the first row (A-D), CK-20 expression in the second row (E-H), and UPIb 
expression in the third row (I-L).  Scale bar = 100 µm. 
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Figure 3.8: Expression of CK-17 in hADSCs within 2 mg/mL collagen type I hydrogel 
cultured in DMEM (A), in KSFM with rat BSMC layer (B), and in KSFM without rat 
BSMC layer (C). Additionally, hADSCs were also stained using Celltracker Red to 
visualize within collagen gel (D-F). Scale bar = 100 µm. 
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Figure 3.9: Comparison of CK-17, CK-20, and UPIb protein expression in hADSCs 
in 3D collagen gel culture after 7 days. CK-17 expression was present in hADSCs 
cultured in KSFM (A), while expression of CK-20 (B) and UPIb (C) were absent. Protein 
expression was absent in undifferentiated hADSC samples cultured under DMEM.  DAPI 
was used for counterstain of cell nuclei.  Scale bar = 100 µm.   
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Figure 3.10: Live/Dead assay of hADSCs. Human ADSCs were encapsulated within 2 
mg/mL collagen type I hydrogel and cultured in DMEM (A-C) and in KSFM (D-F) with 
rat BSMC layer (G).  Since hADSCs were cultured in Celltracker Red (B, E), dead cells 
were identified via overlay (C, F) where green and red cells indicated live cells, and red 
cells indicated dead. Scale bar = 100 µm. 
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3.4. Discussion 
New developments in urinary tissue engineering methodologies have provided 
potential alternative solutions to the current standard of using gastrointestinal tissue and 
buccal mucosa with inherent mismatches in biological properties and function. Of these 
alternative solutions, recent methods in literature have focused on differentiation of 
mesenchymal-derived adult stem cells, which includes hADSCs, using serum-based 
media in co-culturing methods or conditioned medium from multiple cell lines and had 
varied success in terminal transdifferentiation towards urothelial lineage [136-139].  Liu 
et. al. [137] reported that differentiation of hADSCs towards urothelial lineage as 
evidenced by urothelial-specific CK-18 and UPIb expression was a result of direct co-
culture with human urothelial cells and not of indirect co-culture or conditioned media.  
However, Shi et. al. reported increased CK-18 and UPIb expression in hADSCs cultured 
under conditioned medium from human ureter urothelial cell culture [138].  From these 
studies, the particular mechanisms that drive hADSC differentiation towards urothelial 
lineage are not clear, though both studies conclude that it may be due to the local 
environment or secretion of cytokines from the urothelial cells.  However, to elucidate 
the feasibility of hADSCs as alternative cell source for urothelium in clinical translation, 
it is important to avoid the use of autologous urothelial cells [152] and serum-based 
media [156]. We show that hADSCs cultured in defined KSFM exhibited an increase in 
mRNA expression for urothelial-specific markers CK-20, UPIb, and UPII as well as 
presence of CK-20 and UPIb proteins in hADSCs as early as 7 days and up to 21 days. 
Furthermore, rhodamine-phalloidin staining (Figure 3.1) and phase-contrast imaging 
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(Figure 3.2) revealed that hADSCs appear morphologically similar to UROtsa cells in 
culture.  These outcomes were previously obtained only when hADSCs were subjected to 
direct co-culture or conditioned media with urothelial cell lines [137-139].  The results of 
the present study suggest that defined KSFM with its soluble chemical factors can be 
used as a viable alternative method to drive differentiation of hADSCs towards urothelial 
lineage in lieu of serum-based media previously described in literature.  
Urothelial cells in native tissue express cytokeratins of various subsets, which are 
intermediate filament proteins found within the cytoskeleton [160].  Studies have shown 
that the expression of cytokeratin types is highly dependent on location within the 
urothelial layers; CK-17 is expressed only within basal cells, while CK-20 is expressed 
solely in umbrella cells [160]. This expression profile in cytokeratins is typically used to 
demarcate the transition from basal to superficial transition in regenerating hyperplastic 
urothelium [161]. The results of the present study suggest that the expression of 
cytokeratins may be dictated by the extracellular matrix presence, physical environment 
surrounding, and presence of KSFM. Specifically, CK-20 mRNA and protein expression 
significantly increased in hADSCs under both KSFM and KSFM with ATRA conditions 
compared to control hADSCs. However, we noted the downregulation of CK-17 mRNA 
and (Figure 3.3) and protein expression (Figure 3.4-3.7) throughout all time points in 
hADSCs cultured in 2D on conventional TCPS.  In contrast, cells encapsulated within 
collagen gel under KSFM expressed CK-17 (Figure 3.8, 3.9). Because this occurred both 
in the presence and absence of the BSMC feeder layer under KSFM supplementation, we 
speculate that the presence of bladder smooth muscle cells does not affect the expression 
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of CK-17 in hADSCs. Rather, results indicate that growth within 3D collagen matrix and 
supplementation with KSFM both contribute to the expression of CK-17 in hADSCs, and 
could possibly indicate that these hADSCs are differentiating towards a 
basal/intermediate urothelial lineage as opposed to umbrella cell types seen in 2D 
samples.  
ATRA has been previously demonstrated to induce differentiation of adult stem 
cells toward epithelial lineage [165, 166], which was indicated by increased expression of 
cytokeratins [121, 166] and a morphology shift towards a monolayer, contact-inhibited 
growth profile [121]. In the present study, the addition of 5 µM ATRA caused hADSC to 
exhibit epithelial-like cell morphology (Figure 3.1), which is in agreement with a 
previous report [121].  However, compared to hADSCs cultured in defined KSFM, gene 
expression of CK-20 was significantly lower at all time points in hADSCs cultured in 
both DMEM and KSFM with ATRA (Figure 3.3).  Qualitative analysis of western 
blotting and immunofluorescence results agree with gene expression results as marginal 
protein expression of CK-20 in hADSCs cultured with both DMEM and KSFM with 
ATRA (Figure 3.4-3.7) were observed.  This result coupled with the high expression of 
CD90 and CD105 markers indicates greater retention of a stem-cell phenotype and a less 
pronounced shift towards an umbrella cell urothelial-like phenotype when cultured with 
ATRA. The results of the present study confirmed that 5 µM ATRA does appear to have 
an effect on cell morphology in vitro seen previously in literature. However, taken 
together with gene and protein expression results found in this present study, current 
evidence suggests that 5 µM ATRA supplemented in either DMEM and KSFM have 
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negligible effect on hADSC differentiation towards urothelial-specific cell phenotype, but 
rather may only be promoting epithelial cell differentiation.  
Along with the morphology shift (Figure 3.2), another critical morphological 
difference to note was the actin filament profile between different cell types and culture 
conditions.  Romih et. al. previously suggested that a morphological change in 
subcellular distribution of actin filaments can be an indication of a shift in differentiation 
of urothelial cells from basal and intermediate cells towards superficial umbrella cell 
[167].  In the present study, control hADSCs (Figure 3.1A) and hADSCs in DMEM and 
KSFM supplemented with ATRA (Figure 3.1D and 3.1E) exhibted a distinct network of 
bundled actin filaments. In contrast, both UROtsa cells (Figure 3.1B) and hADSCs 
cultured in defined KSFM alone (Figure 3.1C) exhibited undefined distribution of actin 
filaments. The similar distribution of actin filaments between UROtsa cells and hADSCs 
in defined KSFM, which was distinctly different from control and ATRA-supplemented 
samples, provides additional evidence indicating a morphological change in hADSCs 
towards a superficial urothelial cell phenotype.   
One of the most critical markers of terminal urothelial phenotype is the presence 
of uroplakins. The uroplakin family of transmembrane proteins arrange into hexagonal 
asymmetric unit membrane (AUM) particles consisting of an inner (formed by UPIa/UPII 
heterodimers) and outer ring (formed by UPIb/UPIIIa heterodimers) that make up the 
majority of the apical membrane plaques of urothelial umbrella cells [53]. These 
crystalline network formed by uroplakin plaques is thought to contribute to the 
impermeability of the urothelium and modulation of bladder function [163] and are found 
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in both superficial and upper intermediate urothelial cell layers of native tissue [164] and 
primary urothelial cell cultures [53]. In the present study, a significant increase in UPIb 
expression compared to control was observed for cells cultured in defined KSFM with or 
without ATRA at the mRNA (Figure 3.3) and protein (Figure 3.5-3.7) levels.  A 
significant increase in mRNA expression of UPII was also detected in hADSC cultured in 
defined KSFM at 7- and 21-day time points with ATRA and at 14- and 21-day time 
points without ATRA, though the fold-change in UPII expression was only minor 
(approximately 2-fold) in these samples.  Along with upregulation of cytokeratin 
markers, these results provide additional evidence of differentiation of hADSCs towards 
more superficial urothelial populations.  
3.5. Conclusion 
In summary, exposure of hADSCs to defined KSFM induced differentiation 
toward a urothelial-like lineage after 14 days in culture. Evidence of morphology shifts 
and increased phenotypic marker expression has shown for the first time that hADSCs 
are capable of differentiation towards umbrella cells is possible without co-culturing or 
serum-containing medium [156].  Although we presented morphological data and 
significant evidence of differentiation towards urothelial phenotype, further research is 
necessary to conclusively prove that hADSCs can differentiate towards a functional 
urothelial cell type.  This study lays the foundation for use of an alternative cell source 
with a serum-free differentiation protocol towards the goal of functional urothelial 
regeneration in 3D culture, which is pivotal in providing a complete solution to repair of 
damaged bladder.  Future research will investigate the efficacy of pre-differentiated 
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hADSCs to replicate urothelial barrier function via transepithelial resistance 
measurement and dextran permeability assays and to characterize their interaction with 
bladder smooth muscle cells using 3D in vitro co-culture models. 
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CHAPTER FOUR 
 
THE FABRICATION OF MULTILAYER  
UROTHELIAL TISSUE IN VITRO 
 
4.1. Introduction 
 In pursuit of functional tissue regeneration, studies have turned to implantation of 
tissue-engineered constructs developed in vitro with limited success in replicating bladder 
physiology [7-9]. Hydrogels have also been explored in tissue regeneration as a method 
to deliver cells, provide essential growth factors, and control cell growth at a target site 
[132]. Though some success has been shown in regeneration of the urothelium using 
native urothelial cells [133, 134], their use and availability is severely restricted in cases 
of bladder cancer and disease [18]. The use of adult stem cells continues to be a challenge 
in replicating urothelial physiology, as it is not a straightforward task to mimic complex 
characteristics such as urothelial impermeability and rapid changes in the urothelial 
umbrella layer associated with bladder compliance and distention – which is especially 
the case for cells not initially suited for such purposes. 
 One particular method to create a multilayer tissue construct uses a layer-by-layer 
coating technique to deposit a nanoscale extracellular matrix (ECM) on cellular surfaces 
using fibronectin and gelatin [131]. The addition of fibronectin and gelatin films to the 
cell surface provides functionalization, the benefits of fibronectin towards promoting 
cell-adhesion [133], stable cell-cell interactions [134,135], and protection of the cells 
during multilayer tissue formation [131].  
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 In the present study, we test the effects of culturing a 3D tissue construct with 
both hADSCs and UROtsa cells tissue using the fibronectin/gelatin coating technique 
[131].  After performing the layer-by-layer coating technique, the cells are transferred to 
a Transwell® growth membrane and cultured for 24 hours.  Cell morphology and 
phenotype was studied via H&E staining and immunofluorescence on frozen sections, 
and dextran permeability assays were performed to examine barrier function of the 
multilayer tissue construct.  
4.2. Materials and Methods 
Cell culture.  
Human adipose derived stem cells (hADSCs) were purchased from Lonza (PT-
5006) and expanded in low D-glucose (1000 mg/L) DMEM (Life Technologies) 
supplemented with 10% fetal bovine serum (FBS, Fisher), 1% GlutaMAX (Life 
Technologies).  For differentiation towards urothelial lineage, hADSCs at approximately 
2.5x105 cells/cm2 were cultured in defined keratinocyte serum-free media with the 
growth supplement kit provided by the manufacturer (Life Technologies) for 14 days. 
hADSC between passages 3 and 7 were used in all experiments of the present study. 
UROtsa cells, an immortalized normal human urothelial cell line (kindly donated by the 
laboratory of Dr. Naoki Yoshimura, Department of Urology, University of Pittsburgh), 
were cultured in DMEM supplemented with 10% FBS, and GlutaMAX.  All cells were 
cultured under standard cell culture conditions (sterile, humidified at 37°C, 5% CO2) 
Fabrication of multilayer cell constructs 
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In preparation for construct fabrication, bovine fibronectin (Sigma) and gelatin 
were dissolved in 50 mM Tris-HCl (pH: 7.4) to create a 0.2 mg/mL stock solution.  To 
create multilayered hADSC constructs, undifferentiated (control) and differentiated 
hADSCs were coated in alternating layers of bovine fibronectin and gelatin via 
resuspension of cells in 0.04 mg/mL working solution.  Cells were washed between each 
coating step by gentle resuspension in 50 mM Tris-HCl.  After cells were coated in 
alternating layers (5 layers of fibronectin and 4 layers of gelatin), cells were suspended in 
cell culture media and were seeded in 12-well Transwell® inserts (Corning) coated in one 
layer of fibronectin (FN-coated). Undifferentiated and differentiated hADSCs without 
FNG coating were used as control.  In a separate experiment, both UROtsa cells and 
membranes were coated with alternating layers of fibronectin and gelatin (5 layers of 
fibronectin and 4 layers of gelatin) or single fibronectin layer (FN-coated membrane). To 
create 8 layers of cells, 8.0x105 hADSCs and 2.0x106 UROtsa cells were required per 
well, respectively.  For 2 layers of cells in hADSCs, 2.0x105 cells were seeded per well.  
Cells were allowed to culture for 24 hours before further experiments were conducted.  
Histology and immunofluorescence of multilayered cellular constructs 
After the prescribed culture period, hADSCs and UROtsa cells were fixed on the 
Transwell® membrane using 10% neutral buffered formalin, followed by infiltration 
using 30% sucrose for cryoprotection.  Samples were removed from the cell culture insert 
using a scalpel, and embedded in OCT for cryosectioning.  Samples were stained with 
H&E to examine cellular morphology and images were taken using a microscope (Motic 
BA210) and Canon mounted camera (Canon EOS Rebel SL1). Glycosaminoglycans 
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(GAGs) were stained with 1% Alcian Blue in 3% acetic acid at pH 2.5 with s248-Nuclear 
Fast Red 0.1% Kernechtrot (Poly Scientific R&D Corp.) as counterstain following 
manufacturer's protocol.  For immunofluorescence staining, UROtsa samples were 
subjected to blocking solution (5% non-fat dried milk in PBS) at room temperature for 30 
minutes before incubation in mouse monoclonal anti-cytokeratin 17 (CK-17, Sigma, 
C9179), goat polyclonal anti-cytokeratin 20 (CK-20, Santa Cruz Biotechnology, SC-
17113), goat polyclonal anti-uroplakin Ib (UPIb, SCBT, SC-15174), or goat polyclonal 
anti-ZO1 (Santa Cruz Biotechnology, SC-11111) at 4°C overnight. All primary 
antibodies were used at a 1:100 dilution in PBS. Following primary antibody conjugation, 
species-specific fluorescently labeled (FITC or Alexa Fluor 488) secondary antibody was 
added at a 1:1000 dilution in PBS and incubated at room temperature for one hour. Cell 
nuclei were then stained with 300 nM DAPI in PBS for 5 minutes. Fluorescence images 
were taken on a Nikon epifluorescence microscope (TE-2000S) and a Hamamatsu digital 
camera (C4742-95).   
Permeability measurements using fluorescent dextran 
 The barrier function of hADSC and UROtsa multilayer constructs was determined 
via measurement of fluorescently labeled dextran molecules in the lower well of the 
Transwell® culture system. Fluorescein isothiocyanate (FITC) conjugated (4 kDa) and 
Rhodamine B conjugated (70 kDa ) dextran in cell culture medium (2 mg/mL 
concentration, 300 µL per well) was placed on top of a cellular multilayer cultured in 
Transwell® inserts, and wells were filled with 1 mL pre-warmed culture medium without 
tracer to create a liquid interface. Inserts without cells were used as control. Fluorescence 
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measurements of culture medium (1 mL) taken from the abluminal side of Transwell® 
inserts at various time points over a 24-hour period using a Biotek Synergy 4 microplate 
reader at 485 nm and 520 nm excitation wavelengths and 544 nm and 590 nm emission 
wavelengths for FITC and Rhodamine B, respectively. 
Cell Viability Assessment 
 The viability of UROtsa cells was qualitatively assessed using a Live/Dead assay 
kit (Life Technologies) and following the manufacturer’s instructions.  Briefly, culture 
medium was removed and cells were washed 3 times using PBS before adding ethidium 
homodimer-1 (4 µM) and calcein AM (2 µM) dye mixture for 5 minutes.  The 
membranes were cut and removed from the Transwell® insert and imaged (Nikon 
Eclipse TE 2000-S).   
 
4.3. Results 
Histology and immunofluorescence of multilayered cellular constructs 
 H&E stained 8-layered undifferentiated/uncoated hADSCs showed uniform, 
multilayered distribution (Figure 4.1.A).  Conversely, both undifferentiated/coated 
hADSCs (Figure 4.1.B) and differentiated/uncoated hADSCs (Figure 4.1.C) exhibited 
aggregation with incomplete multilayering and lack of defined cell-cell adhesion.  
Cellular detachment from the membrane and severe aggregation was observed in 
differentiated/coated hADSCs (Figure 4.1.D) groups.  Gross examination of the cellular 
construct showed visible aggregation of cells in undifferentiated/coated hADSCs, 
differentiated/uncoated hADSCs, and differentiated/coated hADSCs groups after 24 
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hours.  When hADSCs were seeded at lower density (for 2 layers) cell aggregation 
similar to 8-layer conditions was observed in gross examination (images not shown), 
which correlated with observations shown in H&E stained sections (Figure 4.2).   
 UROtsa exhibited uniform cellular distribution and multilayer formation in both 
coated cells/FNG-coated membrane (Figure 4.3.A) and coated cells/FN-coated membrane 
(Figure 4.3.B) groups.  Uncoated cells on FNG-coated membrane (Figure 4.3.C) 
displayed a scattered, multilayer morphology with cellular aggregation seen in gross 
examination of the Transwell® membrane.  Uncoated cells on FN-coated membrane 
displayed some adhesion to the membrane on the basal layer with lack of cell-cell 
adhesion in superficial layers.  Gross examination of all UROtsa cells shows 
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Figure 4.1: Cell morphology of 8-layered hADSC constructs. Frozen sections of fixed 
differentiated/undifferentiated and coated/uncoated cells on FN-coated Transwell® 
membranes were stained using H&E.  Cellular adhesion to construct was uniform in 
undifferentiated hADSCs (A). Cell aggregation was apparent in undifferentiated/coated 
hADSCs (B), differentiated/uncoated hADSCs (C), and differentiated/coated hADSCs 
(D) Top right images show gross examination of cell aggregation. Scale bar = 100 µm.   
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Figure 4.2: Cell morphology of 2-layered hADSC constructs. Frozen sections of fixed 
differentiated/undifferentiated and coated/uncoated hADSCs on FN-coated Transwell® 
membranes were stained using H&E.  Cellular adhesion to construct was uniform in 
undifferentiated hADSCs (A). Cell aggregation was apparent in undifferentiated/coated 
hADSCs (B), differentiated/uncoated hADSCs (C), and differentiated/coated hADSCs 
(D).  Scale bar = 100 µm.   
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generally homogenous cellular distribution with some aggregation.  Alcian blue staining 
in both hADSC and UROtsa cell multilayers showed absence of GAGs in any samples 
after 24 hour growth period in Transwell® membrane (Figure 4.4, 4.5) 
 Fluorescence imaging revealed strong protein expression of CK-17 throughout 
multilayer construct of UROtsa cells in all samples after 24-hour culture period with no 
particular localization (Figure 4.6).  Distinct CK-20 protein expression was visible in all 
samples with strong expression localized in superficial layers of UROtsa cells (Figure 
4.7).  Protein expression of UPIb was present in all samples with no particular 
localization in any cell layer for coated cells/FNG-coated membrane (Figure 4.8.A).  
Coated cells/FN-coated membrane (Figure 4.8.B), uncoated cells/FNG-coated membrane 
(Figure 4.8.C), and uncoated cells/FN-coated membrane (Figure 4.8.D) expressed UPIb 
though at lesser intensity.  For coated cells/FNG-coated membrane (Figure 4.9.A) and 
coated cells/FN-coated membrane (Figure 4.9.B), protein expression of ZO-1 was well 
defined and distributed in intracellular junctions.  Uncoated cells/FNG-coated membrane 
(Figure 4.9.C) and uncoated cells/FN-coated membrane (Figure 4.9.D) had less-defined 
expression of ZO-1 after 24-hour culture in 3D construct. 
 Cell Viability Assessment 
 Qualitative assessment of the Live/Dead assay on UROtsa cells performed 24 
hours after fibronectin/gelatin coating demonstrated cell viability in both coated and 
uncoated samples (Figure 4.10).  Quantitative assessment via comparison of relative 
intensity values using ImageJ shows 93.0% and 85.0% live cells in uncoated and coated 
samples respectively. 
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Figure 4.3: Cell morphology of coated and uncoated 8-layered UROtsa constructs. 
Frozen sections of fixed coated and uncoated UROtsa cells on FN-coated or FNG-coated 
Transwell® membranes were stained using H&E.  Cellular adhesion to construct was 
uniform in coated cells in both FNG-coated (A) and FN-coated membranes (B).  
Uncoated cells in FNG-coated (C) and FN-coated membranes (D) displayed a scattered 
appearance with cellular aggregation.  Top right images show gross examination of cell 
aggregation. Scale bar = 100 µm.   
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Figure 4.4: Staining for GAG content of 8-layered hADSC constructs. Frozen 
sections of fixed differentiated/undifferentiated and coated/uncoated cells on FN-coated 
Transwell® membranes were stained using Alcian blue and counterstained with Nuclear 
Fast Red.  Alcian blue stain did not show presence of GAG content in 
undifferentiated/uncoated hADSCs (A), undifferentiated/coated hADSCs (B), 
differentiated/uncoated hADSCs (C), or differentiated/coated hADSCs (D). Scale bar = 
50 µm.   
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Figure 4.5:  Staining for GAG content of 8-layered UROtsa constructs. Frozen 
sections of fixed coated and uncoated UROtsa cells on FN-coated or FNG-coated 
Transwell® membranes were stained using Alcian blue and counterstained with Nuclear 
Fast Red.  GAG content was not detected in coated cells on FNG-coated (A) and FN-
coated membranes (B), or in uncoated cells in FNG-coated (C) and FN-coated 
membranes (D). Scale bar = 50 µm.   
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Figure 4.6: Fluorescence imaging for CK-17 in 8-layered UROtsa construct. Frozen 
sections of fixed coated and uncoated cells on fibronectin-coated or fibronectin/gelatin-
coated Transwell® membranes were stained for CK-17 protein.  Expression of CK-17 
was uniform in all samples: coated cells/FNG-coated membrane (A), coated cells/FN-
coated membrane (B), uncoated cells/FNG-coated membrane (C), and uncoated cells/FN-
coated membrane (D).  Scale bar = 100 µm.   
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Figure 4.7: Fluorescence imaging for CK-20 in 8-layered UROtsa construct. Frozen 
sections of fixed coated and uncoated cells on fibronectin-coated or fibronectin/gelatin-
coated Transwell® membranes were stained for CK-20 protein.  Expression of CK-20 
was generally distributed towards luminal side in all samples: coated cells/FNG-coated 
membrane (A), coated cells/FN-coated membrane (B), uncoated cells/FNG-coated 
membrane (C), and uncoated cells/FN-coated membrane (D).  Scale bar = 100 µm.   
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Figure 4.8: Fluorescence imaging for UPIb in 8-layered UROtsa construct. Frozen 
sections of fixed coated and uncoated cells on FN-coated or FNG-coated Transwell® 
membranes were stained for UPIb protein.  Expression of UPIb was present in all 
samples, though most expressed in coated cells/FNG-coated membrane (A).  Coated 
cells/FN-coated membrane (B), uncoated cells/FNG-coated membrane (C), and uncoated 
cells/FN-coated membrane (D) had lower expression qualitatively.  Scale bar = 100 µm.   
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Figure 4.9: Fluorescence imaging for ZO-1 in 8-layered UROtsa construct. Frozen 
sections of fixed coated and uncoated cells on FN-coated or FNG-coated Transwell® 
membranes were stained for ZO-1 protein.  Expression of ZO-1 was generally distributed 
in junctions between cells in coated cells/FNG-coated membrane (A) and coated 
cells/FN-coated membrane (B) samples. Uncoated cells/FNG-coated membrane (C) and 
uncoated cells/FN-coated membrane (D) had weaker and less-defined expression.   
Scale bar = 100 µm.   
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Figure 4.10: Live/Dead Imaging on UROtsa Cells. Imaging of apical surface of coated 
and uncoated UROtsa cells on FNG-coated Transwell® membranes.  Merged image 
displays live cells stained green and dead cells stained red.  Scale bar = 200 µm.   
 
Permeability measurements using fluorescent dextran 
 Fluorescence measurements of dextran molecules diffused into the lower well of 
the Transwell® culture system over a 24-hour period showed significantly lower readings 
in both differentiated/undifferentiated and coated/uncoated hADSCs compared to the 
blank well samples.  Comparison between coated/uncoated and differentiated/ 
undifferentiated groups after 24 hours showed similar effectiveness in preventing passive 
diffusion of dextran molecules (Figure 4.11).  In UROtsa cells, preliminary results 
indicate similar trends to that of hADSCs showing differences in dextran permeability 
between blank samples and cell-seeded samples throughout measurements taken over 24 
hours, but no differences between combinations of cell-coating and well-coating samples.  
Quantitative comparison of fluorescence values for UROtsa groups showed permeability 
was roughly between 45% and 50% for 4 kDa dextran and between 25% and 30% for 70 
kDa dextran compared to the well without seeded cells (Figure 4.12). 
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Figure 4.11: Dextran permeability in hADSCs. Fluorescence measurements for 4 kDa 
FITC-conjugated and 70 kDa Rhodamine B-conjugated dextran permeability taken over 
24 hours in undifferentiated (top) and differentiated (bottom).  Vertical axis numbers are 
arbitrary fluorescence values measured at 544 nm and 590 nm emission wavelengths for 
FITC and Rhodamine B respectively. Error bars indicate ±1 S.D. 
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Figure 4.12: Dextran permeability in UROtsa. Fluorescence measurements for 4 kDa 
FITC-conjugated (top-left) and 70 kDa Rhodamine B-conjugated (top-right) dextran 
permeability taken over 24 hours.  Vertical axis numbers are arbitrary fluorescence 
values measured at 544 nm and 590 nm emission wavelengths for FITC and Rhodamine 
B respectively. Permeability percent ratio was compared for 24-hour time point between 
cell samples under different coating combinations and empty wells (bottom-left). 
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4.4. Discussion 
 The objective of the present study is to develop a multilayer culture construct of 
urothelial cells differentiated from hADSCs for functional tissue regeneration. 
Previously, several cell culture models have been developed to recreate characteristics of 
native urothelial tissue [52, 125-127].  Shiroyanagi et al. [51, 52] reported the preparation 
of transplantable urothelial cell sheets using canine harvested urothelial cells on 
temperature sensitive PIPAAm-bonded surfaces with stratification obtained using cell 
culture medium containing FGF-7 and the 3T3 feeder layer method.  In the present study, 
application of a layer-by-layer fibronectin/gelatin coating technique [131] to both 
UROtsa cells and Transwell® growth membrane resulted in a multilayer tissue construct 
with some characteristics of native bladder urothelium in both morphology (Figure 4.3) 
and phenotype (Figure 4.6-4.9). Although cellular multilayers developed in all groups 
(uncoated cells/FNG-coated cells and FN-coated membrane/FNG-coated membrane), the 
results of H&E staining indicated well-developed, cohesive urothelial-like tissue with 
presence of tight junction proteins, ZO-1 only in FNG-coated cells grown on FNG-coated 
membranes (Figure 4.9).  
 To explore the feasibility of developing an in vitro urothelial cell construct that 
could mimic native tissue function without the use of autologous urothelial cells [18] and 
serum-based media [29], we explored 3D tissue culture with urothelial-differentiated 
hADSCs to determine their functionality in vitro as compared to UROtsa cells. Our 
previous studies demonstrated that hADSCs cultured in defined KSFM could develop 
urothelial-like morphology and phenotype in 2D cell culture evidenced by an increase in 
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mRNA expression for urothelial-specific markers CK-20, UPIb, and UPII as well as 
presence of CK-20 and UPIb proteins. Preliminary results indicated that using the FNG-
coating methods have detrimental effects on multilayer formation of the coated and 
differentiated hADSCs. Specifically, although undifferentiated, uncoated hADSCs 
display a well-developed multilayer construct (Figure 4.1A), uncoated/differentiated and 
coated/undifferentiated hADSCs display slight aggregation of the cells after 24hours 
visible in both the H&E images and gross examination, which could be attributed to 
preferential cell-cell contact in differentiated hADSCs or adhesion to the 
fibronectin/gelatin matrix in coated hADSCs. This effect appears to be amplified in the 
coated/differentiated hADSCs, in which the cells aggregate to form a cluster as seen in 
the gross examination image (Figure 4.1D).  When the procedure was repeated with 
fewer cells (enough for 2 layers, instead of 8), similar results were obtained as 8-layer 
samples where a cohesive cellular layer was obtained in undifferentiated/uncoated 
hADSCs (Figure 4.2A), while scattered growth was seen in the remaining samples 
(Figure 4.2B-D) showing that the initial seeding density of hADSCs in Transwell® 
membranes does not necessarily contribute to cellular aggregation.   
 To explore the effects of the fibronectin/gelatin-coated urothelial cell construct on 
urothelial-like cells in vitro, combinations of uncoated/FNG-coated UROtsa cells and 
FN-coated/FNG-coated Transwell® membranes were explored.  After a 24-hour growth 
period, cells of all four coating combinations showed multilayer growth with minimal 
cellular aggregation in gross examination (Figure 4.3).  In FNG-coated cell/FNG-coated 
membrane, good structural stability and homogenous multilayer growth can be clearly 
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seen in H&E sections with deterioration of such qualities as shown in other groups when 
omitting the cell and membrane coating. In the uncoated cell/uncoated membrane, 
cellular detachment can be seen in the apical layers (Figure 4.3D).  These results provide 
evidence that FNG-coating of both cells and the growth membrane may be required for 
proper development of multilayer tissue construct in urothelial-like cells. 
 Native urothelial cells express various forms of cytokeratins and uroplakins of 
various subsets, which contribute to the structural integrity and functionality of the cell 
[14, 34, 36], and expression of particular protein types is dependent on location within 
the stratified urothelium.  For example, expression of CK-17 can be seen in basal and 
intermediate cells, while CK-20 and uroplakins subtypes are typically expressed in 
superficial cells of native tissue [34, 38].  In our previous study (Chapter 3), results 
suggested that the influence of the ECM and physical environment might determine the 
differential expression of cytokeratins and uroplakins in cell culture.  All samples from 
the present study showed expression of CK-17 in all layers of the multilayer construct 
after 24-hour culture in Transwell® membranes.  Furthermore, stronger expression of 
CK-20 in superficial cells can be seen compared to basal cells in all samples except the 
uncoated-cell/FN-coated membrane sample providing evidence that multilayer 
differentiation begins to occurs within 24-hours.  Expression of UPIb appears throughout 
all layers of the multilayer construct with the lack of stratification in these results 
possibly due to the short culture time in 3D and the presence of uroplakins in all UROtsa 
cells during 2D cell culture.  Overall, it appears that the extracellular matrix provided by 
the fibronectin/gelatin cell and membrane coating provides the necessary 
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microenvironment for UROtsa cells to develop a 3D multilayer construct and express 
urothelial-specific protein markers. 
 A critical function of the urothelial layer is to provide a barrier between the urine 
and the underlying smooth muscle tissue.  In addition to the uroplakins preventing 
passive diffusion via apical membrane plaques on the umbrella cell surface, separation of 
the urine and underlying smooth muscle layer is also regulated by the presence of tight 
junction proteins such as occludin and ZO-1 [14].  Expression of ZO-1 in the cells with 
FNG-coated cells, and lack thereof in uncoated cells, indicate that presence of the ECM 
coating promotes cell-cell adhesion and tight junction formation within 24-hours.  
Dextran diffusion experiments [128, 129] were conducted to determine relative 
permeability through the multilayer tissue samples. Briefly, FITC-conjugated dextran at 4 
kDa and Rhodamine B-conjugated dextran at 70 kDa were used to determine transcellular 
(passage through the apical and basolateral membrane of the cell) and paracellular 
(passage between intercellular spaces) permeability, respectively.  For both UROtsa and 
8-layer hADSC cells, preliminary results suggest that the presence of the cells reduce 
transport of dextran compared to Transwell® membranes without seeded cells. However, 
different FNG-coating conditions or cell differentiation states did not appear to have an 
effect on permeability. Although not clearly visible in the histological examination, 
single-layered cells were present in areas of the Transwell® insert that appear to show 
little to no aggregation upon gross examination.  Cells and ECM present in these areas 
may contribute to the slower diffusion of fluorescent dextran across the Transwell® 
membrane over time. Along with evidence of cellular aggregation in examination of the 
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multilayer morphology, these results suggest that certain essential components for 
epithelial development, such as cell number or provision of growth factors, or maturation 
time is lacking to create a well-developed tissue construct capable of providing a barrier 
function without cellular aggregation.  According to a study by Janssen et al., one 
possibility is the lack of glycosaminoglycan (GAG) presence, particularly chondroitin 
sulfate, on the surface of the multilayer tissue construct, which has been shown to reduce 
urothelial permeability in native human and porcine bladder [130].  From the results of 
the Alcian blue stain, evidence indicates that neither hADSCs nor UROtsa are producing 
GAGs in the multilayer construct after 24 hours.  The time course for cells to begin self-
production of GAGs in the present model are currently unclear, however the lack of GAG 
content may provide another explanation for the incomplete barrier function.  
4.5. Conclusion 
 Preliminary results show that when layer-by-layer FNG coating was applied 
aggregation of differentiated hADSCs begins to occur within 24 hours of cell culture.  
UROtsa results suggest that coating of the Transwell® membrane prior to cell seeding 
could be an important factor in preventing cellular aggregation.  Furthermore, dextran 
permeability results suggest that although there is slowing in the dextran diffusion rate 
across the membrane due to cellular presence in both hADSCs and UROtsa cells, a zero-
diffusion rate of dextran molecules would be necessary to demonstrate barrier function 
closer to what is seen in the native bladder. Although presence of ZO-1 proteins in 
UROtsa suggests some extent of cell-cell tight junction formation, permeability results 
indicate that barrier function is not fully developed in multilayer tissue constructs. 
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Addition of GAG supplement to culture during the seeding process on the apical surface 
of the tissue construct, like seen in native tissue, may provide the necessary component to 
initially assist the barrier against solute diffusion through the membrane prior to self-
production of GAGs by the cells.    
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CHAPTER FIVE 
 
STATIC TENSION BIOREACTOR FOR BLADDER  
TISSUE ENGINEERING APPLICATIONS 
 
 
5.1. Introduction 
 The primary objective for tissue engineered grafts and scaffolds in urology has 
undergone a paradigm shift over recent years.  Research has moved more from a top-
down to a bottom-up approach – rather than providing a basic urine reservoir, but instead 
exploring the use of synthetic and natural polymers to design materials that imitate the 
compliance of the native urologic tissue [143].  In a clinical trial performed by Atala et 
al., PGA composite grafts were seeded with autologous cells and wrapped in omentum 
prior to implantation in 7 patients.  In a 5-year follow up, histological data revealed the 
formation of urothelial and smooth muscle layers, but patients suffered from lack of 
bladder compliance, low urine capacity, and the need for intermittent catheterization 
[169]. Further research would be necessary to better illuminate the mechanisms that are 
key in functional bladder restoration. 
 Starting in utero, the bladder undergoes filling, storage, and urination cycles that 
are important for the physiological development of the urinary bladder.  This cycling 
process causes stimulation in and ultimately leads to replication of bladder smooth 
muscle cells [173].  One approach seeks to couple mechanical stimulation for physical 
conditioning with in vitro tissue maturation in a process termed functional tissue 
engineering. Growing evidence suggests that conditioning tissues with normal 
mechanical stimulation leads to better cellular growth, graft survival, and proper gene 
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expression and cellular bioactivity [174].  On a cellular level, mechanical forces in the 
growth environment of urothelial and bladder smooth muscle cells are critical for 
retention of native cell physiology.  Roby et al. demonstrated that sustained tension on 
bladder smooth muscle cells increase expression of α-SMC indicative of the contractile 
smooth muscle phenotype [170].  Another report in the literature demonstrates that 
mechanical stretch may play a role in Ca2+ influx and ATP release in primary urothelial 
cell culture [171]. In response to these studies, a bioreactor system capable of applying 
constant tension on tissue engineering constructs in a cyclic loading, holding, and 
unloading profile was developed for replication of bladder filling cycles in typical cell 
culture environments. 
 
5.2. Materials and Methods 
Device Design & Construction 
 The tension-controlled bioreactor (Figure 5.1), which had been designed and 
assembled previously in our laboratory [175], was modified and calibrated.  Briefly, the 
setup contains two channels capable of linear uniaxial stretch on small specimens with 
stepper motors (21H4AA-2.5-907, Haydon Kerk Motion Solutions) driven by a chopper 
drive circuit (Model 40105 #EDL9950, Haydon Kerk Motion Solutions) and powered by 
a linear power supply (HC24-2.4, Bel Power Solutions).  On the opposite end, full bridge 
thin-beam load cells (LCL-113, Omega) are placed to measure voltage changes due to 
strain via signal conditioning module (DMD-465, Omega). The stepper motor is 
controlled through a custom designed LabVIEW (National Instruments) program 
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allowing for precise control of linear displacement, which simulates tension associated 
with bladder filling in vivo. The LabVIEW program uses a feedback loop mechanism that 
reads the output force generated by the stretch of the specimen and converts this value 
into tension. The loading rate and maximum stretch, determined by calculations and 
estimations of native bladder filling in the literature, can be controlled through the 
LabVIEW program.  The bioreactor is designed to operate in cell culture conditions of 
humidified, 37°C and 5% CO2 and device components can be sterilized by UV radiation.   
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Figure 5.1:  The tension bioreactor device.  The load cell (A) and linear stepper motor 
(B) attach linearly to a hydrogel construct made in a Teflon mold with Biovyon wafers 
and suspended in wells filled with cell culture media or PBS for hydration (C). 
 
LabVIEW Program Design 
 The LabVIEW program (Figure 5.2) was designed based on state machine 
architecture to transition to the different stages of cyclic loading using a main loop for the 
state machine control, and three separate loops for voltage/force measurements, 
force/distance over time graphing, and load rate calculation (Figure 5.3).  The program 
outline (Figure 5.4) describes the overall logic to determine the current state based on 
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force calculations converted from voltage readings based on a linear calibration 
(Appendix 2).  Prior to executing the main program for bioreactor control, the sample is 
attached to the stepper motor and load cell and a separate program is used to manually 
adjust the stepper motor extension so that the voltage shows negligible tension on the 
load cell. When the program is executed, the initial state is set in which the user will 
specify experimental conditions under parameters such as cycle number, load rate, 
desired force, time target, and voltage offset (Table 5.1). The voltage offset value is 
entered in order to set the initial force reading to zero. Once the experimental conditions 
are determined, the program proceeds to the loading state, sending pulse signals to the 
stepper motor and plots force and distance over time graphs.  When the output force 
reading matches or exceeds the desired force value, the program proceeds to the static 
state and begins a state-specific timer loop, which runs until the time target value is 
reached.  During this time, if stress relaxation in the hydrogel causes the output force to 
decrease below the desired force value, the stepper motor will engage to pull the 
hydrogel.  When the time target value is reached, the program proceeds to the unloading 
state, which will take the calculated displacement value determined from the pulse 
signals sent to the stepper motor and pulse the stepper motor with the opposite voltage 
until it returns to the initial displacement.  When the motor resets the to the initial 
displacement position, one cycle is added to a cycle counting loop and the program 
continues to function until the set cycle number has been reached, at which point the 
program will cease and allow the user to export the plot data to Microsoft Excel.  
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Input Parameter Definition 
Cycle Number Sets the number of full loading, static, and unloading cycles will 
complete before the program halts 
Load Rate Sets the rate (in mm/sec) at which the loading state will run the 
stepper motor and apply strain to the hydrogel construct 
Desired Force Sets the minimum force value (in N) during the holding state that 
will engage the stepper motor if the output force values falls below 
the desired force value.  
Time Target Sets the time (in sec) spent in the static state to simulate a static 
strain period at desired force. 
Voltage Offset Offset value for the output voltage to compensate for minor strain 
initially placed on the load cell due to attachment of the hydrogel 
in order to zero reading values.   
 
Table 5.1: Definitions of initial state input parameters. 
 
T1107 Hybrid Hydrogel Preparation and Loading 
 For calibration of the device, model hydrogel tissue constructs were prepared 
according to an established protocol of our laboratory (REF).  The hydrogel was formed 
by adding Tetronic® T1107 (BASF Corporation) acrylate (117.5 mg/mL) to a collagen 
type I solution of 6 mg/mL dissolved in 0.02N acetic acid overnight. Additionally, a 
photo-initiator compound (Irgacure, I-2959, BASF Corporation, 100mg / 1mL ethanol) 
and hyaluronic acid (MW: 1.5-1.8 MDa, Sigma, 10mg / 1mL H2O) were added to the 
mixture with periodic vortexing to ensure homogeneity. The hydrogel was formed in a 
Teflon mold with a rectangular inset measuring 3cm X 1cm X 0.5cm (Figure 5.5).  Two 
small porous Biovyon wafers (Porvair PLC, Norfolk, UK) were used as anchors for metal 
pins and to allow for an increased area of attachment.  The hydrogel was then removed 
from the mold and connected to the bioreactor device using small rare earth magnets 
glued to the pins using epoxy, and suspended in a phosphorous-buffered saline solution.  
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Figure 5.2:  Front Panel of Tension Bioreactor Program.  The user interface to input 
initial parameters and read output data during static and cyclic loading experiments. 
 
Figure 5.3:  Block Diagram of Tension Bioreactor Program.  The programming 
architecture for the state machine design with multiple simultaneous while loops. 
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The bioreactor was placed into a cell culture incubator at 37°C in a humidified 5% CO2 
atmosphere. 
Calibration of Bioreactor 
 To calibrate the tension bioreactor, three materials, T1107 hybrid hydrogel, 
Parafilm M (Bemis), and a PCUU scaffold, were used.  For each test, the specimen was 
attached to the connecting rods of the stepper motor and the load cell and motor position 
was set to a zero strain position. The T1107 hybrid hydrogel was subjected to static 
tension of 1.0 N for three 600-second cycles with a loading rate of 0.0625 mm/sec. The 
Parafilm sample was attached directly to the connecting rods and subjected to 4.0 N for 
one cycle at 0.2 mm/sec. The PCUU scaffold was subjected to 2.5 N for two 1000-second 
cycles at 0.1 mm/sec.  
5.3. Results 
Calibration of Tension Bioreactor 
 The T1107 hybrid hydrogel sample failed under approximately 0.9 N of force and 
15 mm of linear displacement (Figure 5.6, 5.7).  In contrast, the parafilm maintained the 
applied force at 4.0 N for the duration of the static while the displacement continued to 
climb and the test was halted after 90 seconds (Figure 5.8). From the bioreactor output 
data, a stress/strain curve for Parafilm M was generated (Figure 5.9).  Over the two 
cycles, the PCUU scaffold held a constant force at 2.3 N for the first cycle and at 2.0 N 
for the second cycle while displacement of the motor was maintained at approximately 9 
mm and 6 mm, respectively (Figure 5.10).  
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Figure 5.4:  Logic Diagram of Tension Bioreactor Program.  The programming logic 
flow chart outlines the comparisons made during each state and the Boolean output 
indicating if the program will enter the next state or continue in the current while loop. 
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Figure 5.5: Teflon molds for hydrogel constructs.  Small pins (A) with neodymium 
rare earth magnets (not pictured) are attached to porous Biovyon wafers (B) and filled 
with components for hydrogel formation in the rectangular insert (C). 
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Figure 5.6: Gross examination of T1107 hybrid hydrogel during loading cycle.  
Linear displacement of stepper motor applies force to hydrogel construct (A). Prior to 
reaching the desired force, the hydrogel construct separated due to failure during stretch.  
The orange highlight outlines the border of the hydrogel construct (B). 
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Figure 5.7: Distance and Force vs. Time Plots for T1107 Hybrid Hydrogel on 
Tension Bioreactor.  Linear displacement of stepper motor shows load rate of 0.0625 
mm/sec for the initial loading stage (A).  At approximately 0.9 N of force and 14 mm of 
linear displacement, the T1107 hybrid hydrogel construct separated in the center and a 
drastic decrease in the force detected was observed. 
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Figure 5.8: Distance and Force vs. Time Plots for Parafilm M on Tension 
Bioreactor.  Linear displacement of stepper motor shows load rate of 0.2 mm/sec for the 
initial loading stage (A).  After reaching the desired force of 4.0 N, the change in linear 
displacement reduces to a lower load rate in order to compensate for stress relaxation of 
Parafilm over the remainder of the test. 
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Figure 5.9: Stress/Strain Curve of Parafilm M.  From the initial conditions of the 
experiment, a stress strain curve can be generated from the bioreactor output data in order 
to monitor material behavior during loading tests. 
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Figure 5.10: Distance and Force vs. Time Plots for PCUU Scaffold on Tension 
Bioreactor.  Linear displacement of stepper motor shows load rate of 0.1 mm/sec for the 
initial loading stage (A).  After reaching the desired force of 2.3 N for the first cycle and 
remaining static for 1000 seconds, the stepper motor returns to the origin and begins the 
second cycle (B).  During the second cycle, the output force reaches 2.0 N and remains 
for 1000 seconds. 
 
5.4. Discussion 
 The results of calibration provided evidence that the custom-designed tension 
bioreactor was capable of applying a static force to tissue engineering constructs for a 
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predetermined time period and number of cycles in a physiological environment. The 
bioreactor demonstrated variability in force and distance vs. time profiles based on the 
physical properties of the three test materials (parafilm, PCUU, and T1107 hybrid 
hydrogel).    
 The use of hydrogels for treating medical conditions involving urogenital organs 
at various stages of pre-clinical and clinical tests have begun to appear in new research in 
tissue engineering [35-37, 42, 47, 49, 56, 63-67].  The unique properties of hydrogels 
such as their viscoelasticity and capacity to fine-tune the mechanical properties have been 
key for their adaptation in many applications in tissue engineering [42, 47].  Recently, 
hydrogels prepared with chemically crosslinked Tetronic-acrylate (BASF Corporation) 
polymers have been explored for its potential use as a tissue scaffold in bladder 
applications.  In particular, modified T1107-acrylate hydrogels combined with collagen 
type-I and hyaluronic acid have been studied for its mechanical properties and viability as 
a cellular scaffold in vitro [172]. In the present study, the T1107 hybrid hydrogel 
specimen failed structurally at 1 kPa peak stress and a peak stretch ratio of 1.5.  In the 
previous study, acellular T1107 hybrid hydrogels were subjected to tension at 5 mm/min 
(0.083 mm/sec) until failure, and a peak stress of 4.1 ± 1.2 kPa and peak stretch of 1.21 
±1.23 were recorded [172].  Results in the present study are on the same order of 
magnitude to results obtained previously in uniaxial tensile testing on MTS Synergie 100 
providing evidence for the reliability of the tension bioreactor results.  The differences in 
the values between studies can be attributed to the differences in loading rate or the 
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orientation of the specimen during testing (vertical on MTS vs. horizontal in tension 
bioreactor). 
 When the parafilm was subjected to a constant tension on the bioreactor, the 
material was noted to surpass the yield point and plastic deformation was observed. 
Under the static tension state at 4.0 N, the parafilm strip continued to stretch (Figure 5.8).  
From these results, mechanical properties such as elastic modulus and yield point can be 
determined. In the present study, elastic modulus of the parafilm was 8.7 MPa in the 
initial section of the stress/strain curve with a yield point of approx. 1 MPa (Figure 5.9).   
 Electrospun, wet PCUU scaffolds have been demonstrated previously in our lab 
as a potential bladder tissue substitute scaffold because its mechanical behavior is similar 
to that of native human bladder with respect to maximum tension (PCUU: 0.43±0.029 
N/mm; Native: 0.27±0.14 MPa), stretch ratio (PCUU: 2.43±0.26; Native: 1.69±0.17), and 
tension-stretch curve profiles [175, 176].  Moreover, using the bioreactor in the stretch-
control mode [175] PCUU scaffolds seeded with BSMCs were subjected to 25% uniaxial 
stretch over a 3 hour period (1 hour in loading, static, and unloading states) resulting in 
an increase of cells exhibiting expression of smoothelin indicative of contractile smooth 
muscle phenotype compared to non-stretched groups.  In the present study, the force-
control mode was used to subject the PCUU scaffold to two cycles at the desired value of 
2.5N.  In contrast to the parafilm, the PCUU did not demonstrate plastic deformation 
during the loading cycles indicating that PCUU had not surpassed yield strength.  
Although a number of previous studies have demonstrated correlation between 
mechanical loads applied on cells and cellular/molecular responses such as ECM 
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production, growth factor secretion, and cell proliferation [177, 178], which type of 
stimuli (forces, tension vs. stretch, displacement) triggers these events is not well 
understood.  Thus, the ability to apply mechanically loading to tissue engineering 
scaffolds both in a force-control and displacement-control manner is one of the unique 
features of our bioreactor and potentially useful for the study of functional tissue 
development. In the case of the bladder, where cells are constantly subjected to both wall 
tension and large deformation, it is critical to study the role of mechanical stimuli in 
cellular response and tissue development. 
5.5. Conclusions 
 To date, the tension bioreactor has been designed to apply controlled mechanical 
force stimuli on soft biomaterials intended to reproduce the in vivo bladder filling and 
voiding cycles for the purpose of studying functional tissue engineering.  Conditioning 
cells with cyclic mechanical stimulation may improve the overall tissue physiology, 
which might typically fail after implantation due to compliance mismatch or improper 
cellular ingrowth from the lack of mechanical preconditioning [174]. In addition, 
mechanical conditioning may play a role in the study of neurogenic bladder conditions, 
such as overactive bladder, which may arise during tissue development [63, 68, 84].  The 
tension bioreactor has potential to apply cyclic and static tension to tissue engineered 
scaffolds and soft biomaterials in a fashion that mimics native bladder cycling, which is 
essential to illuminate the mechanisms that are key in functional bladder tissue 
development and restoration.    
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CHAPTER 6 
CONCLUSIONS AND RECOMMENDATIONS 
6.1 Introduction 
 Bladder tissue engineering using synthetic and naturally derived materials has 
made significant progress in recent years, however those in vitro successes have fallen 
short in outperforming current gold standard surgical techniques [143-146].  Still, the 
body of knowledge for functional regeneration of smooth muscle and urothelial tissue 
layers continues to grow.  The present dissertation research explored the effects of the 
chemical and physical microenvironments of cell culture on hADSC differentiation 
towards functional urothelial cells.  First, the use of defined keratinocyte serum-free 
media and all-trans retinoic acid were explored to elucidate their effects on the expression 
of urothelial-specific markers in hADSCs (Chapter 3).  Next, the differentiated hADSCs 
were cultured in a three-dimensional microenvironment using a layer-by-layer 
fibronectin/gelatin scaffold to test the hypothesis that urothelial morphology and marker 
expression could be dependent on the physical environment (Chapter 4). Furthermore, a 
tension bioreactor system capable of applying constant force in a sterile, physiological 
environment was developed to mimic native loading conditions and study force-
dependent cellular activity (Chapter 5). 
 
6.2 Expression of Urothelial Markers in hADSCs due to Defined KSFM 
Supplementation 
 
One approach in tissue engineering is the use of adult stem cells to take advantage 
of their regenerative properties.  Particularly, hADSCs has been shown to exhibit multi-
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potency, immunosuppressive properties, and relative ease-of-harvest [110, 153].  
Furthermore, in developing a system for restoration of urothelium in human patients, 
research indicates that the use of autologous urothelial cells [152] and serum-based media 
[156] should be avoided due to their potential complications when transferring to an in 
vivo environment.  With these goals in mind, the effects of all-trans retinoic acid and 
defined keratinocyte serum free media with supplementation were investigated on 
urothelial differentiation of hADSCs in two-dimensional cell culture (Chapter 3).  The 
mRNA expression profile of hADSCs (increase in CK-20, UPIb, UPII; decrease in CK-
17, CD90, CD105) when cultured in defined KSFM after 14 days indicated 
differentiation away from the hADSCs phenotype and towards a urothelial cell 
phenotype. Western blot and immunofluorescence results confirmed corresponding 
protein translation of CK-17, CK-20, UPIb genes providing evidence that hADSCs 
differentiated towards the urothelial lineage in 2D culture partially shares a phenotypic 
profile with the superficial layer of native urothelium.  In contrast, when hADSCs were 
cultured under KSFM in a 3D growth environment via collagen gel encapsulation, 
protein expression of CK-17 and CK-20 reversed compared to 2D and became closer to 
the basal/intermediate urothelial phenotype.  The results of the present study show that 
ATRA affects cell morphology in vitro by causing a monolayer, contact-inhibited growth 
profile in hADSCs, but has a negligible effect on differentiation towards urothelial-
specific cell phenotype in gene and protein expression. These experiments established a 
novel and reliable differentiation method to drive hADSCs towards a urothelial-like cell 
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lineage using serum-free media and without relying on multiple cell lines for 
supplementation.  
 
6.3 Fibronectin/Gelatin Coating Effect on hADSC and UROtsa Multilayer 
Constructs 
 
Ultimately, functional restoration of the urothelial layer requires pre-differentiated 
hADSCs grow in a 3D microenvironment. To ensure that changes in hADSC phenotype 
due to defined KSFM supplementation are preserved in 3D and thus facilitate 
development of a functional multilayer, the effects of layer-by-layer fibronectin/gelatin 
coatings to create three-dimensional constructs with hADSCs and UROtsa cells were 
explored (Chapter 4). Results indicated that hADSCs, which underwent changes in cell 
physiology under defined KSFM supplementation, aggregate under fibronectin/gelatin 
coating and differentiated conditions when seeding the cells in a 3D microenvironment. 
The present findings show that UROtsa cells, which were used to investigate if similar 
aggregation would occur in a urothelial-like cell population, do undergo some extent of 
cellular aggregation when coated in fibronectin/gelatin. However, use of the same coating 
method on the Transwell® membrane prior to UROtsa cell seeding improves multilayer 
formation, promotes urothelial protein expression, and decreases cellular aggregation 
after 24 hours. In addition to cell coating, fibronectin/gelatin coating of the Transwell® 
membrane could improve the formation of a multilayer in urothelial-differentiated 
hADSCs. 
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6.4 Barrier Function of hADSC and UROtsa Multilayer Constructs 
 
 Results from permeability experiments indicate that both hADSC and UROtsa 
multilayer constructs are not completely impermeable to passive transport of dextran 
molecules (Chapter 4).   Since the presence of uroplakins and tight junction proteins in 
UROtsa cells with FNG-coating was confirmed, these results indicate that other 
components in providing a functional urothelial barrier may be missing from the model 
used in the present study. Studies have shown that glycosaminoglycan (GAG), 
particularly chondroitin sulfate, contributes to an increase in the transmembrane 
resistance (i.e. decrease in urothelial permeability) in native human and porcine bladder 
[130]. Alcian blue stain for acidic polysaccharides indicated that GAGs were absent in 
UROtsa and hADSC multilayer constructs after 24 hours of culture, which suggests that 
the short culture time was not enough for seeded cells to begin GAG production. Recent 
literature indicates that ATRA along with ActA (Activin-A) and BMP-7 (bone 
morphogenetic protein-7) contribute to production of tight junction proteins in ADSCs 
[169]. Though ATRA was excluded from these multilayer experiments due to the 
negligible effect it had on urothelial phenotypic expression, it is possible that ATRA 
could potentially contribute to the formation of a spread, umbrella layer as evidenced by 
the monolayer, contact-inhibition growth pattern.  
 
6.5 The Development of a Tension Bioreactor System to Study Effects of Mechanical 
Stimulation in Sterile Environment 
 
 The custom-designed bioreactor has been calibrated to apply controlled 
mechanical force stimuli to cells seeded on various scaffolds and matrices to improve 
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overall bladder tissue development, which has been shown to fail after implantation from 
the lack of mechanical preconditioning [173]. The bioreactor's unique capability of 
applying a cyclic load representative of bladder cycling would be useful in studying the 
effect of mechanical stimuli on differentiated hADSCs within an in vitro model of 
multilayered urothelium (Chapter 4), which have only been studied in a static growth 
environment to date.  Thus, the tension bioreactor has the distinct benefit of contributing 
to functional bladder restoration via mechanical preconditioning resembling bladder 
filling cycles on various materials used for bladder tissue engineering.   
 
 6.6 Summary 
 In the present study, the results provide novel evidence that, through a 
combination of physical and chemical factors, defined KSFM causes hADSCs to increase 
expression of urothelial-specific mRNA and protein markers of both superficial urothelial 
lineage and decrease expression of mesenchymal stem cell mRNA markers under 2D 
TCPS after 14 days in culture.  Furthermore, administering the same culture regimen for 
7 days in 3D collagen gel culture can induce the protein expression of CK-17 indicative 
of basal/intermediate urothelial-lineage. In UROtsa cells, the results of the present study 
have demonstrated that fibronectin/gelatin coating on both cells and growth membrane 
allow for the formation of multilayer constructs with cytokeratin, uroplakin, and tight-
junction proteins indicative of in vitro urothelial formation.  A tension bioreactor system 
has been calibrated to monitor cellular activity caused by mechanical stimuli, which can 
aid in expanding knowledge of tissue engineering for bladder tissue constructs in vitro.  
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Future experiments have been outlined below as potential avenues for exploration to 
provide new uses for hADSCs in bladder tissue engineering and regenerative medicine. 
 
Recommendations for Future Studies 
• Determine the phenotypic, morphological, and functional changes of both hADSC 
and UROtsa multilayer construct after an extended maturation period (longer than 
24 hours)  
• Determine the effects on cell phenotype and morphology of supplementing 
specific growth factors used in 2D urothelial pre-differentiation to 
undifferentiated hADSCs in 3D. 
• Investigate the use of additional natural or synthetic polymers that may contribute 
to the impermeability of the multilayer construct 
• Develop a testing model for the bioreactor to characterize the effects of 
mechanical stimuli on the multilayer construct, particularly focusing on the 
overall mechanical strength and stability. 
• Investigate the response of urothelial-differentiated hADSCs in co-culture with 
native bladder SMCs or SMC-differentiated hADSCs to determine the efficacy of 
a complete in vitro bladder tissue construct. 
• Investigate the behavior of urothelial-differentiated hADSCs on acellular 
synthetic polymers for bladder tissue regeneration. 
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APPENDIX A 
Human Adipose-derived Stem Cell Encapsulation in PMBV/PVA Polymer 
 After results were obtained showing differences in the phenotypic protein 
expression of urothelial markers in hADSCs grown in collagen gel and on TCPS, the use 
of gel-reversible PMBV/PVA hydrogel was explored to study the effects of a 3D 
microenvironment on differentiated and undifferentiated hADSCs in vitro.   
Human Adipose Derived Stem Cell Culture 
Human adipose derived stem cells (hADSCs) were purchased from Lonza (PT-
5006) and expanded in low D-glucose (1000 mg/L) DMEM (Life Technologies) 
supplemented with 10% fetal bovine serum (FBS, Fisher), 1% GlutaMAX (Life 
Technologies), and 1% antibiotic/antimycotic solution (AB/AM; Life Technologies).  
HADSC between passages 3 and 7 were used in all experiments of the present study. 
PMBV/PVA Hydrogel Preparation 
 PMBV and PVA (kindly donated by Dr. Kazuhiko Ishihara from University of 
Tokyo) polymer were dissolved separately into 1X PBS solution at 5% weight/volume 
solution.  Approximately 1.0 x 106 human ADSCs were suspended in 200 µL of PMBV 
solution and mixed with 200 µL PVA solution to form the hydrogel and allowed to set 
for 5 minutes.  Human ADSCs were pre-labeled with Celltracker Red CMPTX 
(Molecular Probes) prior to encapsulation in PMBV/PVA hydrogel.  DMEM was added 
on top of the PMBV/PVA hydrogel and changed every 2 days over a 10-day period.  
Fluorescence imaging was taken to visualize cells within the PMBV/PVA hydrogel. 
Afterwards, 0.3 M D-sorbitol solution in PBS was gently pipetted onto the compound and 
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incubated in 37°C for 10 minutes with occasional pipetting to dissolve the PMBV/PVA 
hydrogel for protein and RNA extraction.  After 10 minutes, the solution was filtered 
using a 40-µm mesh membrane and then centrifuged for 3 minutes at 1000 rpm.  Both the 
TRIzol extraction method and Qiagen RNeasy Mini Kit were used to isolate total RNA 
from encapsulated hADSCs.  Total RNA was quantified using Thermo Scientific 
Nanodrop 2000c UV-Vis Spectrophotometer.   
RESULTS AND DISCUSSION 
 Fluorescence imaging of the hADSCs encapsulated in the PMBV/PVA hydrogel 
after 10 days show a spherical morphology and limited spreading of the cells indicating 
lack of attachment sites for cellular adhesion.  Additionally, attempts with both TRIzol 
and RNeasy Mini Kit extraction methods yielded insufficient amounts of total RNA 
(TRIzol and RNeasy Mini Kit) and protein (TRIzol method only) to run further analysis.  
The PMBV/PVA hydrogel dissolution and cell extraction process was adapted from 
studies conducted on murine mesenchymal stem cells (C3H10T1/2), and further study 
will be necessary to adjust the extraction process to successfully remove hADSCs from 
the hydrogel microenvironment. Although the use of PMBV/PVA provides an inert 
environment with good cytocompatibility, the difficulty in reliably extracting the cells 
from the 3D microenvironment and lack of multilayer formation within the hydrogel 
prevents its use for as an in vitro model for urothelial-like tissue constructs. 
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Figure A.1:  Human ADSCs labeled with Celltracker Red within PMBV/PVA.  
Fluorescence imaging shows spherical morphology and limited cell spreading for 
hADSCs within hydrogel microenvironment.   
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APPENDIX B 
Tension Bioreactor Voltage-Force Calibration 
 Weights of measured mass were attached to the tension bioreactor load cells and 
allowed to hang.  Forces were calculated from known masses and standard gravity.  
Voltage was recorded at each interval and a linear relationship was established.  
Bioreactor Calibration   
Grams Conv. Force (N) Voltage1 Voltage2 
0 0 0.034 0 
16.76 0.1644156 0.337 0.057 
31.85 0.3124485 0.683 0.106 
46.04 0.4516524 0.84 0.144 
61.5 0.603315 1.29 0.209 
77.65 0.7617465 1.61 0.272 
    
 Multiplier Values 0.478987481 2.826052693 
 
Table B.1: Bioreactor Calibration Table.   
 
Figure B.1: Linear Bioreactor Calibration Chart.  A linear relationship was 
established between calculated force values and the output voltage of the load cell on the 
two channels. 
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